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ABSTRACT 
 
ORGAN DONATION IN JAPAN: 
A LONGITUDINAL STUDY OF QUALITY OF LIFE OF LIVING LIVER DONORS 
 
 
 
By 
Etsuko Soeda 
August 2010 
 
Dissertation supervised by L. Kathleen Sekula 
 Japan is a highly developed country with a gross national product second 
only to the United States. Yet in the field of organ transplantation involving organ 
donation from victims who died from trauma such as automobile accidents and brain 
hemorrhage, Japan is behind all western countries and many developing countries. 
Removing organs from deceased donors was prohibited in Japan until 1997. 
Currently cadaveric organ donation remains minimal and, as a result, patients in 
need of heart transplantation must often pay for surgery performed abroad. One of the 
saddest sights on Japanese streets is a child standing on the street with a poster saying 
“Please donate money for a transplant in the US.” 
Japanese surgeons are among the most skilled. In spite of the fact that there are 
almost no organ donations from deceased victims, surgeons have become extremely 
 v
successful in developing new techniques for organ donation from living donors. To 
operate surgically on a healthy person is unprecedented in medical practice and is 
contrary to the solemn advice of Hippocrates who said, “first do not harm (Gillon, 
1985).”   
The purpose of this dissertation was to longitudinally explore the quality of life 
(QOL) and health status of living donors after the donation.  
The phase 1 study was done in 2002 which measured QOL of living liver donors 
(n=46) by utilizing a QOL tool, the Short Form 36 ® (SF-36®) and a researcher made 
questionnaire. This study showed that the majority of donors (69%) said they completely 
recuperated from the operation, while 32% said they did not. Moreover, living donors 
scored lower on the SF-36® than their controls when measured within a year after their 
surgery, and donors who were more than two years post-surgery had higher scores 
meaning their health status and QOL was better than those within a year after surgery.  
For this phase 2 study, the same living donors were invited to participate, 
including those donors whose recipient died, because the death of the recipient must 
clearly represent a significant emotional trauma to the donor. The same QOL tool, SF-
36®, and the researcher made questionnaire were used in this phase 2 study, and the 
change in their QOL and health status over seven years were examined. 
There were no donor deaths in the donor population, though nine donors were 
admitted to a hospital for a variety of reasons. The majority of donors (61.9%) said they 
had completely recuperated from the operation, while 12 donors (33.3%) said they still 
had some symptoms. The donors who scored lower on the SF-36® from the phase 1 
study scored higher for this phase 2 study. However, many still have minor complications 
 vi
and some lost their income or changed their job after this surgery. Also, donors whose 
recipient died after the surgery showed a lower QOL score even after many years. 
The significance of this study indicates that most living liver donors see 
themselves as having recuperated well, though some still had long-term problems.  
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CHAPTER 1 
INTRODUCTION 
 
Japan is a highly developed country with a gross national product second only to 
the United States. Yet in the field of organ transplantation involving organ donation from 
victims who died from trauma such as automobile accidents and brain hemorrhage, Japan 
is behind all western countries and many developing countries. Removing organs from 
deceased donors was prohibited in Japan until 1997. 
 Currently cadaveric organ donation remains minimal and, as a result, patients in 
need of heart transplantation specifically must often pay for surgery performed abroad. 
One of the saddest sights on Japanese streets is a child standing on the street with a poster 
saying “Please donate money for a transplant in the US.” 
 Japanese surgeons are among the most skilled. In spite of the fact that there are 
almost no organ donations from deceased victims, surgeons have become extremely 
successful in developing new techniques for organ donation from living donors. To 
operate surgically on a healthy person is unprecedented in medical practice and is 
contrary to the solemn advice of Hippocrates who said, “first do not harm (Gillon, 
1985).”  The purpose of this dissertation is to explore the quality of life (QOL) and the 
status of health of living donors after the donation.  
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1.1 Background 
In Japan, living donor liver transplantation (LDLT) has provided a partial solution 
to the severe lack of cadaveric organ donors for the replacement of livers in patients with 
end-stage cirrhosis, fulminant disease, and congenital disorders of metabolism. In view of 
the extreme shortage of organs from deceased donors, Japanese surgeons have developed 
new surgical techniques and pre- and post- operative patient management so that now, 
LDLT can be used in some adult to adult as well as adult to child cases. 
 Nagasue and colleagues (1992) were the first to report a successful living donor 
liver transplantation in Japan in 1989. Prior to this report, children such as those who 
suffered from congenital biliary atresia were beyond the reach of organ transplantation. 
In 1993, a group of surgeons performed the first successful adult to adult LDLT using a 
left-lobe graft (Hashikura et al., 1994). In 1996, surgeons  performed LDLT using a right-
lobe graft successfully to overcome the barrier of graft-size mismatching for adult 
recipients (Lo et al., 1997). Consequently, Japanese society began to recognize liver 
transplantation as a life saving procedure and the demand for LDLT increased. In 2004, 
Japanese National Insurance began to cover medical expenses for LDLT and since that 
time the number of patients who request liver transplantation has continued to increase. 
To date, 4,292 LDLT (Figure 1) are reported from the Japanese Liver Transplantation 
Society (The Japanese Liver Transplantation Society, 2006b). 
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Figure 1.  Number of Liver Transplantation in Japan 
 
 
However, there are clear safety issues for living donors. According to Umeshita 
(2003) the post-operative morbidity for LDLT donors is about 12%, while operative 
mortality is zero. However, one donor death was reported from Kyoto University shortly 
after the Umeshita report (Akabayashi, Slingsby, & Fujita, 2004). In 2006, one donor in 
Gunma University Hospital became a paraplegic because of heparin over-dosage 
(Kiyosawa, 2007). These mortality and morbidity rates are relatively low in comparison 
with those of European and American countries. 
From the nurse coordinator’s perspective, there are many troublesome anecdotal 
notes recorded in reference to nurses and doctors who care for these patients. For 
instance, a nurse reported to a coordinator that a 20 year old female living donor was 
crying alone in her bed unable to sleep thinking of her donor operation, although she had 
gone through the regular consent process and consented to the surgery. Consequently, she 
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underwent the donating operation, because she had a strong wish to save her father. After 
the operation, she expressed her mixed feelings by explaining her family’s sad story. She 
said that she lost her elder brother who had completed suicide two years ago. Since his 
suicide, her father, who was a policeman began to regret the way he had treated his son 
and started to drink heavily, which accelerated his liver damage. This is why she wanted 
to save her father by donation. For this young girl, it took a while to express her reasons 
for wishing to donate. Some young physicians report that it is very hard for them to 
attend a living donor surgery because surgeons have to put a scalpel on the healthy skin. 
Even when the donor operation is performed with minimum risk, the indications of 
transplantation are clear, the living donor gives voluntary informed consent, and the 
living donor has the right to change his/her mind even after signing the consent, the idea 
of living donor liver transplant is still considered to be unnatural by many.  
In the near future, the new Organ Transplant Bill will be revised to be a less 
restrictive one by the Congress of the Japanese government, but it will take a long time to 
take effect in Japan (Table 1). In the meantime, patients who need a liver transplant have 
to depend on living donors in Japan. Therefore, there is a need to determine the quality of 
life (QOL) of living donors and to assess how they recuperate after organ donation. 
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Table 1.   The Original Organ Transplant Bill vs. the Revised Organ Transplant Bill 
 
 Original organ transplant bill Revised organ transplant bill 
Concept of 
death 
Three basic signs of death:  
•  non heart beating 
• non breathing 
• dilation of pupils 
Three basic signs of death 
Brain death 
Brain death If s/he shows her/his will to donate 
on the donor card, brain death will 
be considered as a death. 
Brain death will be considered as a 
death. 
Requirement 
for organ 
donation 
• Older than 15 yr. 
• Has a written consent by 
the donor 
• Need to have a family 
consent 
• No restriction of the age. 
• Consent by the donor 
family is enough for organ  
donation. 
 
 Living donor kidney transplantation, as an altruistic charitable gift between 
members of a family, is generally accepted by Japanese society and health care 
professionals. In 2006, 1,136 kidney transplantations were performed in Japan and 939 
(82.6%) were from living donors (Ota, 2007). Isotani (2002) reports medical 
complications such as pneumothorax, deep venous thrombosis, and wound pain, but 
reports that these complications are treatable and the patients’ QOL is the same as or 
better than in the general population. In a study which compared the QOL of living liver 
donors and living kidney donors (Rudow et al., 2005) it was reported that both groups 
reported favorable outcomes, however living kidney donors had less concern for risk of 
death, bleeding, altered appearance, and infection. That is because laparoscopic removal 
of a kidney is becoming more easily available for living kidney donors. However, the 
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ethics of this have been recently challenged by Scheper-Hughes (2007), Director of the 
university-based “Organ Watch” in the prestigious “American Journal of 
Transplantation.”  She has written on the “Tyranny of the Gift.” She points out that the 
marketing of tissues and organs with commercial organ sales in usually condemned as 
unethical, but many of the objections raised are also relevant to the so called “altruistic 
donation within a family.” She discusses selected cases and points out that female donors 
tend to have more pressure put upon them by family members to sacrifice a kidney than 
males (Scheper-Hughes, 2007). However, an editorial comment was published that was 
critical of Scheper-Hughes’ selection of the worst cases to support her condemnation of 
living donor surgeries in transplant cases (Kaplan & Williams, 2007).  
If there is much higher donor morbidity and mortality in kidney living donor 
transplantation, there is a valid concern that there will be a decrease in the number of 
donors. Therefore, the QOL of living liver donors must be evaluated to determine the 
validity of reports. Transplant coordinators must have a thorough understanding of QOL 
in order to support potential living liver donors based upon that knowledge. 
1.2 Significance of the Study 
Living donors are healthy people who volunteer to undergo a major operation to 
save a loved one. This is a unique situation and it is important to assess how they 
recuperate after surgery longitudinally, over time. Investigation of QOL issues will help 
the transplant team become aware of the resources needed to improve living donors QOL. 
This information may help transplant teams to better understand what interventions might 
help enhance QOL for living donors. Further, by understanding what is relevant to the 
living donors, appropriate information, counseling, and anticipatory guidance can be 
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provided when potential living donors make the decision to donate. The transplant team 
should provide ethically-congruent total care for transplant recipients, living donors, and 
their families. This may help the Japanese public to understand the real benefit of organ 
transplantation and to increase understanding of organ donation in general and the need 
to accept brain death donation (as defined in the Revised Organ Transplant Bill). 
1.3 Research Questions 
1. What is the self-perceived quality of life (as measured by the SF-36®) in a 
sample of living donors seven years post surgery? 
2. Does the self-perception of QOL (as measured by the SF-36®) in the study 
sample of living donors change over a 7 year period? 
3. Does the self-perception of QOL in the study sample of living donors differ 
when compared with norms established for the general Japanese population? 
4. Do the living donors in this sample who had a lower QOL score improve over a 
7 year period? 
5. Have the living donors in this sample received any medical treatment over the 
last 7 years because of organ donation? 
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CHAPTER 2 
REVIEW OF THE LITERATURE 
 
2.1 Introduction 
The first part of this chapter explains the theoretical framework which guided this 
research. The second part defines quality of life (QOL) as it was utilized throughout this 
study.  
2.2 Theoretical Framework 
 The practice of all health care professionals is, at its very core, ethical in its raison 
d’etra. Regardless of whether it is day-to-day decisions, or dilemmas that require 
prolonged thought and analysis, it is important that those in health care take seriously the 
discipline of bioethics (ethics for the health professions).  Health care has changed 
dramatically over the past decades due to the development of new technology, and can be 
seen in the examples of the dilemmas related to organ transplantation, genetic 
engineering, surrogate mothers, and euthanasia. New bioethical problems occur more 
frequently and do not have easy answers.  The dilemma of whether it is ethical to take 
organs from a living donor for the sake of another is a valid question. The answer is not a 
simple “yes” or “no”, but it requires serious consideration of moral values.  Therefore, to 
guide this study the author has chosen the theory of Symphonology (Husted & Husted, 
2008).  Symphonology is a bioethical theory that is concerned with agreements within “a 
set of standards of behavior, preconditions necessary to agreement and professional 
interactions in the health care setting.” (p. xvii ).  
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No research studies were found by this researcher which used this theory 
previously in the Japanese population. This theory has just been published in Japanese 
(Husted & Husted, 2009). However, the situation in which Japanese patients make 
decisions about their health care is similar to that in the US. Whenever patients meet with 
their physicians, nurses attend in order to assure that patients understand all information 
they are given. In cases involving transplant recipients and donors, interviews with 
psychiatrists are mandatory. Both recipients and donors receive all information (full 
disclosure) from their physicians and nurses before making decisions, are given the right 
to make their decisions based on their own judgment, and to withdraw consent at any 
time. Since this is what would be required by the theory of Symphonology, this 
researcher believes the use of this theory for Japanese subjects is culturally applicable 
and ethically germane. 
 “Symphonia” is a Greek word meaning “agreement.” Thus, Symphonology is the 
study and exploration of agreement in the health care setting, the agreement that exists 
between patients (both recipient and donor) and health care professionals. A 
symphonological bioethical outlook is formed from the rational nature of health care 
providers and patients and the nature and purposes of the health care setting. For 
interaction between rational agents to be possible, there must be an agreement between 
them, formulating the terms of their interaction. Husted & Husted’s bioethical theory is 
derived from this agreement. The Symphonological bioethical theory is a practice-based 
approach to ethical decision making and it gives a firm foundation for the patient’s trust 
with the health care professional/patient agreement (Husted & Husted, 2008). 
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Agreement is a shared state of awareness, a meeting of the minds, on the basis of 
which interaction occurs while the agent is one who initiates action or one who is capable 
of taking an internally generated action (Husted & Husted, 2008). Here, a shared state of 
awareness includes recipient and donor in which the health care professionals allow them 
to act as their own agents. The agreement is usually an implied agreement, not spoken, 
but generally understood. There are six bioethical standards that are preconditions to the 
agreement, namely, autonomy, freedom, self-assertion , objectivity, beneficence, and 
fidelity (Husted & Husted, 1995). The conditions of each of these standards as 
preconditions of any agreement must be met with both donor and recipient before it is 
morally acceptable to consider going ahead with the surgery. The following, as defined 
by Husted and Husted: 
1. “Autonomy” as uniqueness. A person’s right to be what he or she is and to be 
dealt with according to that uniqueness. A right to take individual action. A donor 
has the right to make the decision to donate based on his or her own individual 
uniqueness.  
2. “Freedom” as self-directedness. An agent’s capacity and consequent right to take 
independent actions based on the agent’s own evaluation of a situation. A donor 
must be free to make the decision to donate based on his/her own evaluation and 
life-plans. 
3. “Self assertion” as self-ownership and control. The right of an individual to be 
free of undesired or undesirable interaction; the right to control one’s time and 
effort; the right to initiate one’s own actions. A donor must be willing to donate, 
without any coercion or undue interference from others. 
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4. “Objectivity” as a willingness to know something as it is apart from emotion or 
personal prejudice. The living organ donor must be medically and psychologically 
suitable to make the decisions to donate – able to evaluate the facts of the 
situation for self. Furthermore, a donor must be fully informed of the risks and 
benefits for self as a donor and have the right of refusal at anytime. 
5. “Beneficence” as a person’s action based on the intention to do no harm 
(Hippocrates) and do good. A donor should be fully informed of the risks and 
benefits for self, free of pressure or feelings of guilt brought on by others. The 
donor must be able to weigh that which is deemed beneficial or harmful to self. 
6. “Fidelity” as a patient’s faithfulness to his/her values. A donor has the right to be 
faithful to his or her own life and make this decision based on his or her own life-
plans.  
Although each donor decides after thorough consideration of both the risks and 
benefits of live organ donation, there will always be fear of surgery, pain, complications, 
and death. Potential donors may find it difficult to express fears and to find a 
compassionate individual to whom they can express their worries and mixed feelings. 
Moreover, feelings will change from time-to-time depending on the context. For instance, 
a donor might feel happy when her/his recipient survives and recovers from the 
operation, but will feel sad when her/his recipient dies after the operation. In addition, 
there may be severe feelings of guilt if the person decides not to be a donor and the 
person cannot find another donor and dies. Therefore, these donors need to be continually 
assessed and supported by the transplant team.  
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 Because the living donors were healthy before being a donor or having surgery, 
they will expect a full recovery from the surgery and a good QOL, similar to, or the same 
as, before surgery. A living donor’s life experience affects how s/he will use her/his own 
uniqueness (autonomy) in making decisions about being a living donor and in his/her 
perception of QOL.  
As with every decision, each donor makes in the process of donor evaluation, the 
context is of central importance. What is and is not appropriate is influenced by the 
context. For example, whether we wear a light or heavy coat will depend on the weather, 
namely the context. In organ donation the context is more complex, the donor must have 
time to assess the situation to make an informed decision that includes self and the 
recipient.  
There are three elements of the context. First is the context of the situation. The 
context of the situation are those aspects that are found in the situation and necessary to 
understanding the important relevant factors which enable one to act effectively within 
the situation. Second is the context of one’s knowledge. It is the person’s preexisting 
knowledge that one brings to each and every situation. A donor must have complete and 
accurate knowledge of the facts involved in being a donor.  Third is the context of 
awareness. It is our awareness of the situation and our own body of knowledge that 
enables us to act and to understand all aspects of a complex interaction (Husted & 
Husted, 2008). The nurse needs to make sure that the donor and recipient have ongoing 
information as the situation unfolds so that their context of knowledge is accurate and 
complete and can be used to make decisions within the given context. Without this they 
are not aware of the pertinent aspects from which they must make decisions.  
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  For LDLT, the context of the situation will involve progress of the recipient’s 
liver damage, relationship to the recipient, the motivation of living donation, and the 
emotional status of the donor. Especially, in the case of acute onset of the liver damage, 
such as fulminant hepatic failure, the donor has to make a decision within a few hours to 
save the recipient’s life. On the other hand, in the case of the late onset of liver damage, 
such as viral hepatitis B and C, the donor has a time to make a decision after completion 
of the medical treatments. The context of knowledge will be preexisting knowledge 
relevant to the situation of the recipient and donor. The donor will use his awareness of 
the situation and the aspects of his or her body of knowledge to prioritize the relevant 
aspects in the situation. The context of awareness bridges this gap between knowledge 
and situation so that the best decision can be made for this person at this point in time. 
These three elements are interwoven and brought to bear on the care and 
decisions that need to be made for and with any donor. In this way, the standards are 
contextually applied and each application of them is unique for each donor (Figure 1). 
Application of the Husted & Husted’s Symphonological Bioethical Decision 
Making Model to LDLT can help donors, recipients, and the transplant team to establish 
strategies to help them experience a better QOL after organ donation. 
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Figure 2. Husted’s Symphonological Bioethical Decision Making Model II.(Husted & 
Husted, 2008) 
 
 
2.3 History of Liver Transplantation in Japan 
A history of transplantation in Japan   
There are two periods in the history of organ transplant in Japan. One is the period 
before the passage of the Organ Transplantation Bill and the other is the period after the 
passage of the bill in 1997. 
Before the passage of the Organ Transplantation Bill (~1997)   
The history of organ transplantation in Japan began with a kidney transplant in 
1956 performed at Niigata University (Amemiya, 1999). It was only two years after the 
first clinically successful kidney transplantation between identical twins performed at the 
Peter Brent Brigham Hospital in the US in 1954 (Harrison, Merrill, & Murray, 1956). In 
1964, the second kidney transplant was performed at Tokyo University and the first liver 
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transplant was performed at Chiba University. It was a year after the first clinically 
successful liver transplantation by Starzl at Colorado University Hospital in 1963.  
 While patients started to recognize transplantation as a real hope to survive, 
surgeons were struggling to find a way to overcome rejection. In 1959, 6-Mercaptopurine 
was reported as an immunosuppressive agent by Schwartz and Damashek shown to 
prolong survival of renal allografts by Calne (1960). In 1961, Calne reported 
Azathioprine as an effective immunosuppressive agent with fewer side effects (Calne, 
Alexandre, & Murray, 1962). In 1963, it was used clinically by Murray and his team. The 
discovery of new immunosuppressive agents especially Cyclosporin, transformed organ 
transplantation to a confident medical procedure (Calne, 2007). 
 There was an optimistic assumption for Japanese surgeons that they could start 
organ transplant programs using those drugs. However, the first trial of heart transplant 
stopped those developments in Japan. 
 In 1967, the first heart transplant from a cadaveric donor in the world was 
performed in the Republic of South Africa. The next year, Wada, one of the heart 
transplant surgeons who was trained in the United States returned to Japan and performed 
the first heart transplant from a cadaveric donor in Japan. The recipient lived for 83 days 
after the transplant. Right after the transplant, Wada was a hero as a successful heart 
transplant surgeon, but he was accused of being a murderer after the recipient’s death and 
the transplant was then seen as an illegal human experimentation. After this incident, the 
subject of organ transplantation and brain death became controversial and emotionally 
charged for Japanese people (Kaai, Hirano, & Koguro, 1998). 
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 While the development of transplantation in Japan ceased, Starzl performed the 
first successful liver transplantation (Starzl, Marchioro, Porter, & Brettschneider, 1967) 
and Calne performed the first successful liver transplantation in Europe (Calne, 1968), 
and both these groups established the principles of transplantation procedure. Moreover, 
in 1978 Calne introduced the new immunosuppressive drug, cyclosporine, for kidney 
transplantation and that drug made organ transplantation a more successful procedure 
(Calne et al., 1978). In 1983, the use of cyclosporine had become more common and 
organ transplantation was accepted worldwide as a life saving procedure (Sayegh & 
Carpenter, 2004) 
 In 1985, the Japanese Ministry of Health and Welfare established an ad hoc 
committee on brain death, and the committee developed national criteria for brain death 
which was called Takeuchi criteria (Takeuchi et al., 1987). In 1987, the Japanese Medical 
Association acknowledged that brain death was equivalent to death of the human being. 
In 1992, the Prime Minister’s Special Committee on Brain Death and Transplantation 
visited some transplant institutes in both the United States and European countries and 
presented the final report saying that brain death is death of the human being and that a 
donor’s prior intention to be an organ donor is necessary for organ removal (Saegusa, 
1999). However, the report of that committee also stated objections concerning the idea 
of brain death (The Japanese Transplant Network, 2004). 
 After the 1992 report was submitted, many years of discussions about organ 
transplantation and brain death ensued. No transplant was performed to save patients with 
end stage organ failure. There were many changes in the government and frequent 
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dissolutions of parliament did not provide enough time for discussion of the organ 
transplant bill to advance. 
 In the meantime, the first live-donor liver transplant (LDLT) was performed in a 
pediatric patient who suffered from biliary atresia in Brazil in 1988 (Raia S, 1989). 
However, the patient did not survive. The first successful case was performed by Russell 
Strong in Australia (Strong et al., 1990). The same year, the first LDLT was performed in 
Japan. Right after the transplant, the surgeon, Nagasue, was accused of performing 
surgery on a normal healthy mother, a live donor. However, he became a hero when the 
child recovered after the surgery and the mother was well. After this success, LDLT was 
acknowledged as a realistic hope for patients with end stage liver disease in Japan for 
whom previously the only alternative was death. 
After the passage of the Organ Transplant Bill (1997)   
In 1997, the Organ Transplant Bill was passed and brain death was acknowledged 
as equivalent to human death. In 1999, 31 years after the first heart transplant performed 
by Wada in 1968, the first brain-dead donor was procured. It was like daybreak after the 
long dark days and years in the history of organ transplant in Japan. However, the new 
law has proven to be difficult to implement, because of many restrictions. The Congress 
is therefore currently reviewing the law to facilitate organ donation. 
 According to the Japan Organ Transplant Network, from 1997 to 2007, 250 
patients received organ transplantation from 65 brain-dead donors in Japan. The number 
of brain-dead donors is still small but the number of saved patients is significant. The 
average length of waiting time for kidney transplant patients is 5,276 days; for heart 665 
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days, for lung 656 days, and for liver 572 days. This is a long period of time compared to 
western countries (Network, 2008). 
 Therefore, there are more organ transplantations from living donors than deceased 
donors in Japan. To date, more than 4,000 LDLTs have been performed in Japan and the 
advances of surgical techniques and medical management of recipients expanded the 
indications for transplantation (The Japanese Liver Transplantation Society, 2006a).  
2.4 The Role of the Transplant Coordinator in Japan 
In countries where organ transplant is recognized as a valuable surgical treatment, 
the role of the transplant coordinator is clear and plays an important part in every organ 
transplantation program. To become a transplant coordinator, nurses must acquire basic 
knowledge about transplantation and must have special training in caring for both the 
donor and the recipient.  
The traditional role of the nurse since the time of Florence Nightingale is to 
comfort the sick. In LDLT, the nurse/coordinator has to comfort the healthy donor 
suddenly plunged into a strange environment and who is often frightened and in pain. 
The hallmark of good nursing is to make sure the patient is clean, has food and drink, and 
to explain the nature of the illness, the treatment and the prognosis (Marriner-Tomey, 
1994). Thus the role involves the nurse acting as advocate for the patient who frequently 
is unable to appreciate the best option for her/his management and the well-being of their 
family. The nurse should liaise with doctors and others involved in the care of LDLT 
donors. 
Living organ transplantation offers a new dimension in healthcare which has 
slowly become recognized and has evolved into a new area of practice for clinicians. For 
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the first time in medicine, in the case of living donors, healthy people are subject to 
surgical assault, the consequences of which inevitably involve pain and discomfort. There 
may be the possibility of serious morbidity (i.e., leakage of visceral contents, failure of 
wounds to heal) and there is always the risk of mortality. The risk of mortality is low in 
kidney donation, less than one in a thousand, but is significantly higher in liver grafting 
especially in transplantation of half of a liver between adults where there is the danger of 
serious morbidity of around 12% for the donor, due to bile leak, infection, and liver 
insufficiency, among others (Umeshita et al., 2003).  
A living donor may be perfectly willing to take the risk. However, there are more 
considerations than just the individual in question. These may include the family of the 
donor and whether the donor is responsible for the care of children, financially and/or 
emotionally. Most living donor transplant programs will not accept an under-age donor 
giving a kidney or part of a liver to a parent, yet some centers accept child-to-parent 
grafts as a routine procedure in Japan. The coordinator is clearly aware of these matters 
and is closely involved with the families of both the donor and the recipient. It is 
impossible to avoid the whole question of donation and receipt of the organ. Some 
members of the family may feel pressured to be a donor and feel guilty if they refuse, but 
if they accept and they suffer disability or die, their families may feel extremely resentful. 
The question of payment to the donor is an important matter, which may not be 
obvious to the doctors and nurses or even the coordinator. Thus, for example there may 
be monetary coercion involved in the negotiations with potential donors. Those involved 
with obtaining a donor for the recipient may offer financial help in the purchase of a 
house or relief from debt. The coordinator or health care providers rarely know about 
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these coercive practices. The various ramifications of generosity, guilt, recrimination, 
general worry, and concern are an unnatural burden to inflict on a healthy person but it is 
a consequence of the success or failure of transplantation. There are matters that are hard 
to bear for the care givers of the patients involved who are the potential donors. As has 
been stated there is a tendency of over enthusiasm about live donation on the part of the 
recipient as well as the doctors and the institution where the operation will be performed. 
Therefore, the international transplantation community have debated the ethical concerns 
of organ donation and Abecassis published a consensus statement on the live organ 
donation which a transplant team must follow (Abecassis et al., 2000). This is consistent 
with Husted’s bioethical theory. Table 2 outlines the consensus statement on live organ 
donors on the statement. 
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Table 2. Consensus Statement on Live Organ Donors  
Premise • Organ donor should be competent, willing to donate, free from 
coercion, medically and psychosocially suitable, fully informed 
of the risks and benefits as a donor, and fully informed of the 
risks, benefits, and alternative treatment available to the 
recipient.  
Informed 
consent 
• Understanding - Donors must understand accurate information 
regarding risks and benefits to themselves. 
• Disclosure - Description of the evaluation, the surgical 
procedure, and the recuperative period. 
• Anticipated short- and long- term follow-up care. 
• Alternative donation procedures, even if only available at other 
transplant centers 
• Potential surgical complications for the donor, citing the reports 
of donor deaths (even if never experienced at that transplant 
center) 
• Medical uncertainties, including the potential for long-term 
donor complications 
• Any expenses to be borne by the donor 
• Potential impact of donation on the ability of the donor to obtain 
health and life insurance 
• Information regarding specific risks and benefits to the potential 
recipient 
• Expected outcome of transplantation for the recipient 
• Any alternative treatments (other than organ replacement) 
available to the recipient 
• Transplant center-specific statistics of donor and recipient 
outcomes 
• Voluntary nature - Transplant center must ensure that the 
decision to donate is voluntary 
• Documentation - The usual informed consent and the 
documentation of the disclosure process are needed. 
Medical 
suitability 
• Potential living organ donor should be healthy adults (aged 18 
years and older) 
• Selection of the potential donor is based on an algorithm of 
suitability that includes radiological imaging of the liver (to 
assess the following intrahepatic anatomy: hepatic artery, portal 
vein, hepatic veins, and bile ducts), liver volumetric data, and 
the presence or absence of steatosis  
• Heart, lung, and kidney tests 
Psychosocial 
suitability 
• Evaluate psychological, emotional, and social stability 
• Evaluate the competence of the donor to give informed consent 
• Evaluate and discuss the possibility of coercion of the potential 
donor. 
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Final statement –  
The transplant team, donor advocate, and the potential donor and recipient pair are the 
responsible parties who should determine if the benefits of the planned donation 
outweigh the risks. The risks of a complication to the liver kidney donor are not the 
same as the risks for being a live donor of a liver, lung, intestine, or pancreas. These 
highly specialized donor procedures should only be performed at centers with the 
necessary management resources and only by surgeons with appropriate expertise. 
There must be agreement among the potential donor, recipient, and physicians for 
living organ transplantation to proceed. Transplant physicians must have decision-
making autonomy that prevents undue pressure on the medical team to perform a 
procedure that they do not believe is medically indicated. While the autonomy of the 
potential donor must be respected, so also must the medical decision making of the 
transplant team be respected. Therefore, the team should never feel obligated to 
perform a transplant from a living donor if it believes that it will do more harm than 
good. 
 
Nevertheless it must be accepted that the donor may be motivated by truly 
altruistic feelings and it is questionable whether medical and nursing observations should 
interfere with such wishes. Altruism is a genuine emotion, but it is incumbent upon the 
medical and nursing staff to make all the facts known to the various parties. Donors who 
agree to a major and potentially dangerous procedure should be made aware of, and 
should be told in careful and simple language, about the possibility that all their efforts 
might be in vain if the graft is rejected. To circumnavigate these issues is difficult and an 
emotionally draining role of the transplant coordinator. In the situation of living donor 
transplantation, the transplant coordinator will take a role as an advocate for a living 
donor and a counselor for a recipient and her/his family. 
The difficulty of accepting the concept of brain death   
Most Japanese are Buddhists and the essential teachings of Buddhism are 
different from other religions. Buddhism involves the teachings of the Buddha, just as 
Christianity involves the teachings of Jesus Christ and Islam involves the teachings of 
Mohammed. Yet, there is one major characteristic that is unique to Buddhism, and this is 
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that those who embrace Buddhism can also become Buddhas (Takada, 2006). In 
Christianity, Judaism, and Islam, believers are encouraged to learn the teachings of the 
founder and to devote themselves to a unique, absolute deity, but human beings cannot 
become a deity. However, in Buddhism, by learning the teachings of the Buddha, and 
awakening to the truth concerning the universe and human beings, anyone is said to be 
able to become a Buddha. Hence, it can be said that ultimately Buddhism is everyone’s 
attempt to become such a Buddha (Takada, 2006). To become such a Buddha, traditional 
Japanese believe that a complete body is needed. For example, there may be patients who 
ask to keep bones of the amputated leg. 
There are a number of similarities between Buddhism and Christianity (Takada, 
2006). First, Buddha and Christ are the respective founders of Buddhism and 
Christianity. They both devoted their lives to the propagation of their respective truths 
and to saving people. Moreover, the Buddha has two aspects: that of a human, and that of 
one who has attained enlightenment. This is also true of Christ, who has a human aspect 
and a divine aspect as the savior Christ. The teachings of both continue to give 
encouragement and support to many people around the world. 
The difference between the two lies in their teachings (Takada, 2006). In contrast 
to Christ, who preached devotion to God as an absolute being, the Buddha denied the 
very notion that an absolute existed. It also seems that there was a difference in how the 
two propagated their teachings. In contrast to Jesus who commanded that when the 
disciples went forth as missionaries they should go in groups of two or more, the Buddha 
told his disciples to go alone. It appears that during the time of the Buddha there was 
relative peace, whereas in the time of Jesus, Israel was under the control of Rome and 
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there were many violent uprisings and dangers. The deaths of the two were also quite 
different. Christ was arrested and crucified, but the Buddha lived to be eighty years old 
and was said to have been mourned at death by every living entity (Takada, 2006). For 
Japanese, the presence of the family at the death is very important and most people still 
believe that the cessation of the heart beat is the real death; therefore this difference may 
be another reason why the Japanese have difficulty in accepting brain death. 
Deceased Organ Donation in Japan   
For the reasons outlined above, the number of organs transplanted from dead 
donors in Japan is extremely low. Ten donors were identified in the whole of Japan in 
2007. In contrast the head of the liver transplantation program in Valencia, the third 
largest city in Spain, often receives offers of 8 donors in one week (J. Mir, personal 
communication, May 7, 2007). In the past 20 years, more than 2,500 kidneys and 2,100 
livers have been transplanted in Valencia, all from deceased donors. The overall Spanish 
transplantation activity and results are excellent (Matesanz & Miranda, 2002). 
 By attempting to understand the Spanish success in obtaining organs from 
deceased donors, perhaps some of their practices could be adopted in Japan.  
1. Organ donation coordinators are employed in all Spanish hospitals. Most are 
experienced medical doctors, whose responsibility is to identify potential donors 
in their hospitals. They are trained to interview the relatives sympathetically and 
they liaise with intensive care staff and arrange for the diagnosis of brain death by 
suitably qualified neurological experts (Matesanz, 2003). 
2. Spanish law provides for an “Opt-out” framework. In other words, all people 
in Spain are considered to be a potential donor, unless they opt-out in advance. 
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Organs can be removed from brain dead patients, provided they have not 
registered as not willing to donate organs after death for transplantation. If the 
wishes of the deceased are not known, the relatives will be asked if they know of 
the deceased opinion on organ donation. An “Opt-in” law requires explicit 
permission from the next of kin in each case even if the donor had carried a 
“willing to donate organ after death” card. An “Opt-out” law facilitates organ 
donation as a good and charitable act and enables the coordinator to work without 
opposition from and lack of cooperation by nursing and medical staff, which often 
occurs with “Opt-in” laws (Matesanz, 1998). 
3. Sufficient intensive care beds and operation room space are available to take 
care of the potential donors, so that organ failure can be prevented and organ 
removal instigated promptly by an experienced surgical and nursing team 
(Matesanz, 2003). 
4. The government is seen by the people to be sympathetic to organ donation and 
the media are encouraged to explain to the public the benefits of organ 
transplantation and its ethical justification (Matesanz & Miranda, 2002). 
5. Government funds are provided to pay the donor family a grant towards the 
funeral expenses (Manyalich, 2007). 
6. The doctors, nurses and all health care workers involved in the organ donation 
are paid properly for extra hours worked, especially during the night and over 
holiday periods (Manyalich, 2007). 
Naturally, Spain is proud of the success of their deceased organ donation 
program. The average number of donors per year is 40 patients per million in the 
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population, compared to only 20 patients per million in the UK and 0.08 patients per 
million in Japan. This cannot be attributed just to the higher rate of road traffic accidents 
in Spain compared to that in the UK and Japan, but also to a much greater resolve of the 
government to provide financial and physical resources to minimize the number of 
potential donors whose organs are not used for transplantation. It is clear that for Japan to 
improve its deceased organ donation record, much work will have to be undertaken to 
convince central government, the public and healthcare professionals that the effort 
would be worthwhile in providing the gift of life for many doomed patients and avoiding 
the shame of sending patients abroad for treatment that could and should be available in 
Japan. 
An Asian example of responses to the “Opt-out” law was recently outlined by 
Vathsala (2007) from Singapore, where following the passing of the new law, the donor 
rate increased 10-fold reaching 10 donors per million per year, the highest rate of 
deceased organ donors reported by any Asian country. All people in Singapore are 
considered to be a potential donor, unless they opt-out in advance and this law facilitated 
organ donation as a good and charitable act. 
The media   
As might be expected the media in Japan have been fascinated with the story of 
transplantation and they take advantage of the many opportunities to portray human 
anguish, guilt, pain and suffering, and ethical considerations. There have been many 
programs, articles, and books written about organ donation and one recent Japanese TV 
production has raised important questions in the form of a Japanese soap opera.  
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In Japan, many people are informed about current issues through soap operas. In 
one example, the central character was a man in his 40s with end-stage hepatitis C 
although he appeared rather fit on the TV. The question of live organ donation was raised 
since the chances of getting a cadaveric liver in Japan are so low. The patient’s brother 
was identified as a possible donor and he was anxious to give half his liver despite the 
dangers explained to him by the coordinator. But his wife opposed organ donation 
pointing out that her husband was the bread-winner and should consider the welfare of 
his family. Nevertheless the brother persisted in his wish to be an organ donor and he was 
worked up for this procedure. He was summoned to the hospital for a scan and was 
involved in a road traffic accident on the way to the hospital. He ended up in the intensive 
care ward “brain dead”. His wife was furious with his brother for initiating the organ 
donation process and blamed him as being the cause of her husband’s death and she 
refused permission for his liver to be used as a cadaveric brain-dead donor.  
Both the wife and the daughter were evaluated but were not appropriate donors. 
The soap opera was typical in that it highlighted many issues that can occur in such a 
situation. The ending showed the wife being wheeled into the operating room next to her 
husband after being reevaluated and accepted as a donor. 
While one must keep in mind that this was simply a soap opera , it served to 
outline some of the major issues in live organ donation and also address the issue of the 
poor record of cadaveric organ donation in Japan, which means that Japanese patients 
requiring an organ that cannot be given by live donation, e.g. a heart, or multiple organ 
donation for a child, have to beg in the streets for sufficient money to travel to America, 
Australia, or Europe and have the operation done there, which seems a sad reflection on 
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the state of organ donation in Japan. The implication of this media portrayal of organ 
transplantation may be seen as an effort to emphasize that this vital and scarce form of 
treatment should be regarded by the nation as something that should be available to its 
citizens. This TV program may be seen as an attempt to influence the attitudes of the 
Japanese population regarding cadaveric organ donation and acceptance of the procedure 
as a necessity. 
An “opting-out” system whereby organ donation from brain-dead victims would 
be regarded as standard procedure unless objections had been made by the relatives has 
been helpful in certain European countries (Table 3), reducing the anguish of decision 
making at the time when brain-death is diagnosed (The Nippon Hoso Kyokai, Jan. 28, 
2009). The use of living donors needs to be carefully scrutinized to avoid the abuses of 
payment, coercion, and excessive enthusiasm to find a donor. These ethical matters will 
be of increasing importance in the foreseeable future as the results of transplantation 
continue to improve. 
Table 3. Methods to Obtain Informed Consent for Organ Donation  
 
Written consent by a donor is needed (Opt-in) Japan 
Agreement by a donor or his/her family is 
needed (Opt-in) 
US, Germany, England, Australia, 
Holland, Canada, Denmark, Korea. 
Without denial of organ donation, all potential 
donors can donate (Opt-out) 
Austria, Belgium, France, Spain, 
Italy. 
 
Problems in Living Donation 
There is a reluctance to discuss the mortality of adult-to-adult liver transplant and 
worldwide no precise data are available. However it is probably in the region of 1 to 2 %, 
although experienced and skilled centers report less than half this number. Five donors 
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have themselves been in need of a liver transplant as a result of donating half of the liver 
and only one of these five donors was rescued (Ringe et al., 2008). Unfortunately some 
transplants are done by inexperienced surgeons or by skilled itinerant surgeons in 
environments which do not have appropriate infrastructure for pre- and post- operative 
care. Sometimes the fate of the donor is not known to the surgeons who have operated, 
for example when a patient develops delayed infection, or pulmonary embolism after the 
surgeon has flown home. 
There is little doubt in the minds of most citizens that donation of a kidney or a 
quarter of a liver to a close family member can be justified, providing the operation is 
performed by skilled surgeons in institutions with an appropriate infrastructure. This was 
highlighted in the first identical twin transplant between minors, where the Massachusetts 
Supreme Court ruled that the operation should proceed; otherwise the potential donor 
would be denied the opportunity to help a twin and would feel guilty subsequently when 
the sick twin died. For parent-to-child or adult-to-adult kidney transplantation, again the 
procedure is acceptable provided there is a good chance of success and the recipient is 
not suffering from some serious co-morbid disease, e.g. cancer or heart failure. For liver 
transplantation the situation is less easy to explain, especially if an adult-to-adult 
transplantation is proposed; and even more so, if the recipient suffers from hepatitis C or 
cancer which may recur in the graft and the hepatitis C virus may well lead to progressive 
liver failure. 
The limitations of the value of data from questionnaire-alone studies are well 
known. The change in perception over a period of time was illustrated in the following 
personal case study. A 5 year old child needed a liver transplant. For medical reasons the 
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parents were not suitable as donors and the siblings were too young to be donors. A large 
extended family was aware of the child’s predicament and an unmarried female second 
cousin volunteered to be a donor. She was very positive despite frequent discussions with 
doctors and coordinators explaining risks, she was determined to try to save the life of her 
second cousin.  
The operation went well. Eighteen month later, the recipient was fully recovered 
and had normal liver function, but I was distressed to receive a letter from the donor’s 
father who was angry and stated that his daughter’s quality of life had been severely 
impaired as a result of organ donation. In addition to the pain and worry of the operation, 
she suffered severe hiccups whenever she ate and was frightened to go out and socialize. 
The letter went on to say that although the recipient had greatly benefited from the 
operation, the donor’s life and his daughter’s malaise forced him to conclude that, from 
the point of view of his own close family, the liver transplant had been a failure. 
It is possible that the perception of the donor may change, for the better or worse, 
over the next few years depending upon symptoms and the long-term outcome of the 
recipient. 
2.5 Definition of Quality of Life 
In Japan, the most universal definition of QOL is based on that of the World 
Health Organization which is “A state of complete physical, mental, and social well-
being not merely the absence of disease”(WHO, 1997). There are many definitions of 
QOL in the medical and nursing literature. For instance, Calman views QOL and “the gap 
between the patient’s expectations and achievements”(Calman, 1984). Therefore, the 
smaller the gap, the higher the QOL is projected. Testa and Simonson described QOL as 
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"the physical, psychological, and social domains of health, seen as distinct areas that are 
influenced by a person's experiences, beliefs, expectations, and perceptions" (Testa & 
Simonson, 1996). Schipper and colleagues defined QOL as "the functional effect of an 
illness and its consequent therapy upon a patient as perceived by the patient" (Schipper, 
1983). Their depiction includes a description of 4 dimensions of QOL: physical and 
occupational function, psychological state, social interaction, and somatic sensation. 
2.6 QOL studies in Living Donors 
The method of living liver donation was first developed as a life saving procedure 
available for children by providing living liver donations from their parents. In recent 
years, a remarkable increase in adult living donor liver transplantation is recorded. More 
adults now receive living donor transplants in Japan than children (The Japanese Liver 
Transplantation Society, 2005).  
Research studies focusing on living donors began to increase after the numbers of 
living donor transplantation started to increase around 2000. In 2001, Trotter reported the 
result of a survey of living donors to determine the effect of right hepatic lobe donation 
on quality of life using the SF-36®. Major complications occurred in 16 % of patients, 
and minor complications in another 16% of patients. Seventy five percent of patients 
answered that they recovered fully at a mean time of 3.4 months (Trotter et al., 2001). 
Beaver and colleagues (2001) studied living donors using a questionnaire and the SF-
12®. They reported complications requiring readmission in 22% of their respondents 
with a mean recovery time of 3 months. They then reported no significant change in the 
SF-12® scores. Kim-Schluger (2002) also measured QOL of living donors using the SF-
36® and found that donors whose recipients had major complications scored significantly 
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lower on the mental health scale than those with recipients without major complications. 
Walter (2002) studied patients from a psychosomatic perspective and found that 26 % of 
donors showed high scores for tiredness, fatigue, and limb pain following donation. 
However, post-operative complications appeared to have no influence on these 
psychosomatic outcomes. 
An explanation for the percentage of complications being slightly higher in the 
Walter study versus the Trotter study may be due to the use by Walter of a broader 
definition of complications. Walter used a broader Clavein classification of complications 
which has been used for QOL after liver resection and liver donation (Erim, 2006).   
While research describes the difficulties of living donor liver transplantation in 
Japan, little is known about quality of life and other outcomes after living donor liver 
transplants in Japan. A phase 1 study was undertaken to measure quality of life and health 
status in living donors in Japan immediately after, and up to 6 years after the surgery. 
Living donors were excluded from the phase 1 study if the recipient had died (Beavers et 
al., 2001). This introduced a bias that will be addressed in the definitive study. 
2.7 Phase 1 Study: QOL Research in 2002 
In 2002, QOL was studied in a sample of living donors after surgery (Soeda, 
2004).  The purpose of the phase 1 study was to describe the QOL perceived by living 
liver donors and their physical, social, and emotional recovery after having donated an 
organ.  By assessing their perception of their QOL and evaluation of their physical, 
social, and emotional recovery after an organ donating operation, it was projected that 
transplant teams will be better able to help patients improve their QOL 
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Research Questions 
The research questions addressed in this phase 1 study were as follows: 
1. What is the self perception of quality of life of the living donor as 
measured by the SF-36® QOL assessment tool? 
2. Does this perception differ from the perceptions of QOL when compared 
with the data of the healthy control group, a group of healthy people in 
Japan who were given a general population survey of Japanese version 
of SF-36®? 
 
Operational Definitions 
 Living donor.  An individual who donated a portion of her/his liver for the 
purpose of LDLT in Keio University Hospital. The living donor had been within 6th 
degree of relationship and 3rd degree of unrelated relatives to their recipients (The 
Japanese Liver Transplantation Society, 2004). All living donors gave voluntary 
informed consent after meeting with surgeons and a psychologist.  
 Living donor liver transplantation (LDLT).  An operative procedure that a portion 
of liver was transplanted to a recipient who was in a life-threatening condition with end-
stage liver cirrhosis, fulminant disease, or congenital disorders of metabolism (Tanaka & 
Yamada, 2005) 
Short Form 36 ® (SF-36®).  A quality of life assessment tool which was licensed 
by the Medical Outcomes Trust (MOT), Health Assessment Lab (HAL), and 
QualityMetric Incorporated. Its Japanese version was introduced via iHope, International 
in Japan. The SF-36® was designed for use in clinical practice and research, health 
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policy evaluations, and general population surveys. The SF-36® includes multi-item 
scale that assessed eight health concepts: 1) limitation in physical activities because of 
health problems; 2) limitations in social activities because of physical or emotional 
problems; 3) limitations in usual role activities because of physical health problems; 4) 
bodily pain; 5) general mental health (psychological distress and well-being); 6) 
limitations in usual role activities because of emotional problems; 7) vitality (energy and 
fatigue); and 8) general health perceptions (Fukuhara et al., 2002; Fukuhara & 
Suzukamo, 2004). 
 Quality of Life.  “A state of complete physical, mental, and social well-being not 
merely the absence of disease”(WHO, 1997). For this study QOL was measured by 
Japanese version of SF-36®. 
 Healthy Control Group.  A group of healthy people in Japan who were given a 
general population survey of Japanese version of SF-36®. 
Assumptions 
2.7.1.1 The self report of QOL by competent patients and healthy 
individuals was valid. 
2.7.1.2 Valid QOL data were required for the development of appropriate 
nursing interventions and for the ethical decision making for living 
donor candidates. 
Limitations 
1. The subjects consisted of patients who were being followed at one of the 
metropolitan university hospitals in Tokyo, Japan. Because there was a 
limited number of LDLT, the number of cases in the convenience 
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sample was small. Therefore the result of this study must be interpreted 
with statistical caution. 
2. The control group was a Japanese Norm Group reported from the group 
who developed the Japanese version of SF-36®.  
3. Unless there were a 100% response rate, there was the potential of non-
respondent bias. 
4. The condition of their recipients tended to bias the result of their 
perception of QOL. 
Methodology   
Procedure.  The donor evaluation protocol followed at Keio University Hospital was 
approved by their ethics committee in 1995. Potential donors were between 20 and 60 
years old within 6th degree related or 3rd degree unrelated to the recipient. A transplant 
surgeon first described the evaluation process, surgery, postoperative care, and possible 
complications, including death. A review of the program and the literature regarding the 
morbidity and mortality associated with living donation was discussed with potential 
donors during an initial meeting concerning living donation. Most patients and potential 
donors requested further information after this meeting. They wanted to know more about 
the possibility of death. 
A donor surgeon then conducted a stepwise assessment of medical and 
psychological suitability. Potential coercion by the medical team or family members and 
inappropriate motivation by guilt or unrealistic expectations were explored. A 
psychiatrist assessed stress and family support as well as the competency of the donor to 
give informed consent. The possibility of death or serious medical complications 
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occurring in either the donor or recipient and the possibility that the operation may not be 
completed if counter indications where found prior to the surgery. 
A transplant team met weekly to review each potential donor/recipient pair. An 
independent committee not connected with the transplant team, such as pediatrician and 
hepatologist, also met regarding each case. This independent committee then conducted 
an additional stepwise assessment of medical and psychosocial suitability. Potential 
coercion by the medical team or family members and inappropriate motivation by guilt or 
unrealistic expectations were again explored.  
After the independent committee reviewed and approved each case, the 
committee’s decision was discussed with both the recipient and donor. Then, both 
recipient and donor signed informed consent forms. At this time, the transplant team 
made sure that their decision was kept confidential but both recipient and donor 
understood that they could change their minds before surgery. 
Sample.  Between April 1st 1995 and December 31st 2001, 46 living donors were enrolled 
in the study. Six donors whose recipient died after the transplantation were excluded from 
the study.  
Survey Methods.  The chief of both adult and pediatric transplant teams called each 
transplant recipient to explain the purpose of the phase 1 study. The donor was most often 
a parent, sibling, or child therefore doctors asked the recipients to explain the research to 
their donors. Other donors were contacted by the research team. All recipients understood 
the reason and purpose of this research and they agreed to explain to their donor who then 
agreed to participate. Verbal consent was given to the transplant surgeon, the researcher 
did not ask for written informed consent. Then, questionnaires were sent by mail post-
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operatively and consisted of 30-questions written by the transplant team (appendix A) 
and a standard SF-36® questionnaire (appendix B). The questionnaires assessed the self-
perceptions of the donors’ health after the donation, social support during the donating 
process, and the donor’s thoughts about organ donation in general.  
Because there was a question regarding their sexual relationship and for other 
reasons of confidentiality, the researcher explained in the letter that donors did not need 
to write their names on the questionnaire. The letter explained that the mailed 
questionnaires would be returned to a person who was not part of the transplant team. 
However, the researcher provided a place to write their names on the questionnaire if 
they wished and most of the donors included their name. All questionnaires were mailed 
back with researcher-provided envelopes which had different identifying stamps by 
which the research team was able to identify each participant. The researcher was able to 
match the questionnaire with each donor.  
The SF-36® questionnaire is a validated survey that measures general health-
related quality of life. It measures eight domains of physical and mental function. 
Numerical scores assigned to each category are used to generate composite scores: 
physical components score (PCS) and mental components score (MCS). The general 
population of the Japanese has average PCS and MCS scores of 50 with a standard 
deviation of 10. 
Results.  The letters (appendix C) and the questionnaires were sent to 46 living donors 
post-surgery. Forty one donors (average years after the surgery 2.4 years, median 1 year) 
responded by mailing the questionnaires back to the researcher for a response rate of 
89.1%. All respondents were Japanese, approximately half were male (n=20) and half 
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female (n=21). Mean donor age was 38.7 years (range 22-65 years). More than half of the 
donors worked full-time or part-time prior to surgery (n= 25, 61.0%). Twenty two donors 
were parents of pediatric patients and 19 were spouses or siblings of adult patients.  
There were no deaths in the donor population. Major complications were seen in 7 
patients for a total complication rate of 17.0%. Complications included bile leak (n=5) 
and paralytic ileus (n=2) (Table 4). These complications were treated without any 
invasive procedure within 1 year postoperatively. 
Table 4. Major Complications  
 
Graft (n) Right (12) Left (24) Left Lateral (20) 
Biliary leakage 1 3 1 
Bowel Obstruction 0 0 2 
Delay GI passage 0 3 3 
 
The majority of donors (69.0%) said they completely recuperated from the 
operation, while 32% said they did not. Interestingly, 5.0% said they felt better than 
before the operation, because they had stopped drinking alcohol and smoking in order to 
be a suitable donor. The majority of donors (76.0) complained of some minor 
complication such as abdominal discomfort, numbness, and/or fatigue, although no 
donors had any limitation to their activities of daily living. On average, donors reported 
that they felt fully recovered 17.3 (±11.4) weeks after the operation, and they returned to 
work after 8.1 (±7.8) weeks. Half the donors (53.0 %) suffered from adverse financial 
affects due to the LDLX, 50% of whom were unable to have a paid vacation.  
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The majority of donors said they were willing to donate their organs should they 
become brain dead and 34% had already signed a donor card. Concerning their decision 
to donate, all donors signed informed consent forms twice, before starting the donor 
evaluation and before the donor operation, ten donors (24.4%) said they felt pressure to 
be a donor by the medical staff and thirteen (31.7%) said they felt pressure to be a donor 
by their recipient or family members. They reported that when they thought back on the 
situation, only 5% said they would have preferred the recipient to have had a brain dead 
donor, while 76% said they had never thought of the matter. Overall, 88% the donors 
were satisfied with the donation, 12.0% were not sure whether they were satisfied or not, 
but none said they were dissatisfied. 
 Figure 2 shows the mean values for the SF-36® numerical scores comparable to 
the Japanese general population. The mean scores of donors who were surveyed within a 
year after the surgery scored lower than those of donors followed for longer periods and 
the general Japanese population. Also, the scores of mental health of most donors were 
lower than the Japanese general population. Interestingly, scores on some areas of the SF-
36® were higher than the Japanese general population, such as “general health” 6 years 
after. 
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Figure 3. Result of cross-sectional SF-36® score 
 
2.8 Summary of Research Gaps 
The phase 1 study demonstrated that living donors in Japan scored lower on the 
SF-36® than their controls when measured within a year after their surgery. Donors who 
were more than two years post surgery had higher scores meaning their health status and 
QOL was better than those within a year after surgery. Because Japan is a country which 
depends mainly on living donor transplantation, it is important to study the outcome 
measures for living donors after surgery. No research has been conducted longitudinally 
post-surgery. As the demand of living donor transplantation increases, there is a great 
need for QOL and health status studies in this population. The purpose of this dissertation 
research is to look at the longer term effects of living donor transplantation on quality of 
life and health status. 
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CHAPTER 3 
METHODOLOGY 
 
3.1 Introduction 
The methodology chapter explains the design of the study, the setting, and the 
sample. Also included is a description of the data collection instruments. The procedure 
for data collection, protection of human subjects, and the data analysis can also be found 
in this chapter. 
3.2 Design of the Study  
This investigation is a non-experimental longitudinal, descriptive study to 
determine the health-related quality of life of living donors in Japan. Quality of life was 
measured using the SF-36® (appendix B). Detailed information regarding each living 
donor was measured by a researcher designed questionnaire for phase 2 (appendix C). 
The data obtained from living donors was compared to the profile of the general Japanese 
population. Then, the aggregate data at time 2 (phase 2) was compared to the aggregate 
data at time 1 (phase 1) study. 
3.3 Setting 
The site for this study was a teaching hospital which has a living liver 
transplantation program in Tokyo, Japan. In this organization, the management of 
medical care involves all major departments and specialty areas, and the continuation of a 
medical and nursing education program. A commitment to thorough medical 
management is emphasized by the identification of the hospital as a specific center of 
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excellence, especially as an organ transplant center. With highly trained specialists, 
advanced equipment, research, graduate resident and inter/national fellowship programs, 
and nurses and physician practice and involvement these organizations have continued to 
deliver a high quality of care to all. The coordinator is closely involved in all aspects of 
the procedures for organ transplantation from the initial assessment of donor and 
recipient and their families through the operations and the early and late follow up. 
3.4 Sample 
Living donors of the phase 1 study [n=41] were invited to participate in this 
second study. Since the death of the recipient clearly represents a significant emotional 
trauma to the donor, in this study living donors whose recipient died were also invited to 
participate [n=6]. Therefore, the total number who were invited to participate in this 
study was 52 [n=52]. The participation of these subjects was strictly on a voluntary 
basis.  
3.5 Data Collection Instrument 
Two instruments were used to collect data for this study, the SF-36® and the 
researcher designed questionnaire for phase 2. 
The SF-36® was developed to survey health status in the Medical Outcomes 
Study in the United States (Fukuhara & Suzukamo, 2004). The test was developed in an 
attempt “to develop a general health survey that is comprehensive and psychometrically 
sound, yet short enough to be practical for use in large-scale studies of patients in practice 
settings” (Fukuhara & Suzuka, 2001). The SF-36® includes one multi-item scale that 
assesses eight health concepts: (1) limitation of physical activities (physical functioning) 
due to health problems (i.e., effects on daily activities such as pulling a table, lifting 
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groceries, climbing stairs, walking a couple of blocks); (2) limitation of social activities 
(social functioning) due to physical or emotional problems (i.e., effects on social 
activities such as visiting friends and relatives); (3) limitation of usual role activities due 
to physical health problems (i.e., effects of physical health issues on working hours or 
daily activities); (4) bodily pain, namely, assessment of pain severity and how pain 
affects ability to work; (5) general mental health in terms of psychological distress and 
well-being (i.e., levels of anger, sadness, happiness); (6) limitation of usual role activities 
due to emotional problems (i.e., effects of emotional issues, such as depression or 
anxiety, on work or daily activities); (7) vitality (i.e., questions about the subject’s 
assessment of his/her levels of energy, tiredness); and (8) general health perceptions (how 
the subject feels about his/her own health). 
The SF-36® was developed by Ware and Sherhorne in 1992 and was adapted for 
the Japanese population by Fukuhara and Suzuka (2001; Fukuhara & Suzukamo, 2004). 
This tool had become one of the most popular QOL evaluation tools in Japan.  
The researcher developed questionnaire for phase 2 includes 17 questions about 
general information, physical recovery, social activity, and thoughts about their decision 
making in regards to living donor liver transplantation (Appendix C). The purpose of the 
use of a questionnaire was to elicit the responses from living donors in regards to their 
experience of live organ donation. Using the researcher developed questionnaire provided 
the opportunity for study subjects to express additional information about their physical 
recovery, social activity after live donation, and thoughts about living donation in 
addition to the items of the SF-36®. 
 
 44
3.6 Procedure for Data Collection 
The researcher mailed a letter to living donors to inform them about the study 
ahead of time. Two weeks later, the researcher mailed informed consent forms and two 
questionnaires, SF-36® and researcher made questionnaire, with a self-addressed 
stamped envelope for return.  
3.7 Procedure for Protection of Human Subjects 
The researcher obtained Institutional Review Board (IRB) approval from both 
Duquesne University and Keio University. Ethical considerations, such as the privacy, 
dignity, and comfort of the living donors were addressed at all times during the study. 
The living donors were informed of their rights and asked to read the consent form. All 
questions were answered by the researcher. The study subjects were advised that they 
were free to withdraw from the study at any time. The benefits of the study, such as 
improving the care for living donors, were explained to the living donors. In addition, 
there are no known risks for participating in the study. All study data are stored in the 
researcher’s locked drawer under supervision of the university. Data will be properly 
destroyed at the completion of the study and dissemination of the results.  
3.8 Procedure for Data Analysis 
The data were analyzed using the Statistical Package for Social Sciences, version 
14.0 J. (SPSS, Chicago, IL). For descriptive analysis, data are expressed as mean values, 
median, and standard deviation. A comparison with the phase 1 study for the SF-36® was 
conducted through t-test. For all tests, a significance level of p<0.05 was set. 
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CHAPTER 4 
RESULTS 
 
4.1 Introduction 
The purpose of this study was to collect data which would describe the QOL of 
the living donors who participated in the phase one study in 2001. The total sample of 
this study consisted of 36 living donors. There were 52 eligible participants for this study. 
Of those participants, three questionnaires were returned “undeliverable,” making the 
possible participants 49, thus making the response rate of 36 participants, 73.5% of 
potential participants. 
4.2 Description of the Sample 
Thirty six donors (years after the surgery average 10.1 years, median 11 years) 
responded to the researcher’s request to participate in the study. All respondents were 
Japanese, approximately half were male (n=15) and half female (n=21). Mean donor age 
was 50.2 years (range 34-74 years). More than half of the donors worked full-time or 
part-time prior to surgery (n= 25, 69.4%) and a similar proportion of the donors are 
currently working full-time or part-time (n=28, 77.7%). Twenty three donors were 
parents of pediatric patients and 13 were spouses or siblings of adult patients. The 
recipients from five donors (13.9 %) died after the surgery. Of these five cases, three 
recipients died within three months and two recipients died several years after the surgery. 
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Table 5.  Description of the sample (Phase 1 and Phase 2) 
 
 
Phase 1 (n=41) Phase 2 (n=36) 
Mean age  38.7 years (range 22-65 year old) 
50.2 years 
(range 34-74 year old) 
Mean years after the surgery  2.4 years 10.1 years 
male                           20 male                            15
Sex  
female                        21 female                        21
parent                         22 parent                         23
Relationship to a recipient 
souse/siblings            19 souse/siblings            13
Ethnicity Japanese                    41 Japanese                    36
 
4.3 Results 
The Researcher Designed Questionnaire for The Phase 2 
About health conditions.  The majority of donors (61.1%) said they completely 
recuperated from the operation, while 12 donors (33.3%) said they still had symptoms 
(Figure 4). Interestingly, two donors said they felt better than before the operation. These 
two donors did not report feeling better than before the surgery when asked in the phase 1 
study. Especially, one donor had a difficult time and her QOL score was lower than the 
Japanese general population after the surgery in the phase 1 study, but she answered that 
she reported feeling better than before in the phase 2. Also, she answered open-ended 
question, “How do you feel better than before”, as “I started running in order to recover 
from the donor surgery, and I have got back my strength to complete 100 km (=62.5 
miles) marathon. The average period for donors to feel that they recovered from the 
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Phase 1 Phase 2
Recuperated
Not- 
recuperated 
operation was 11.5 (±14.5) months, complaining of some limitation of daily activity for 
an average of 11.7 months (±11.4). Thirty six percent of donors felt they recuperated 
quicker than they expected, 33.3% said they recuperated as they expected, and 30.6 % 
said they recovered more slowly than they expected. 
Figure 4. Post-operative recuperation 
 
Of the 12 donors who said they had not recuperated well, eight said they 
recuperated more than 75% of their wellness, two 50~75%, and one 25~50%. The one 
who answered that she recuperated 25~50% did not state the reason why she felt that way, 
but she was the one who developed breast cancer after donor surgery. Those two who 
answered that they recuperated 50~75% stated their reasons as “Fatigue” and “Diarrhea.” 
One said that he had been having diarrhea after every meal without exception. The eight 
donors who recuperated more than 75% stated their reason as, “Scar”, “Fatigue”, 
“Psychiatric disorder”, and “Abdominal hernia.”  
When they were asked whether they had any limitation when doing physical 
activities, such as playing golf, swimming, business trip, working for long time, and 
traveling, 32 donors (88.9%) answered that they used to have some limitation but no 
limitation now, and the average length they had limitations was 11.7 (±14.5) months 
after the surgery. Four (11.1%) donors answered that they still had some limitations. Of 
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those 4 donors, two said that they had limitation when they went swimming. Because 
they had a big scar on their abdomen, they still hesitate to go to public pools and the sea. 
One donor said that he had a limitation because he had back pain. The other one did not 
answer the question.  
In terms of minor complications, more than half of the donors (n=20, 55.6%) 
suffered from pain for the average length of 7.5 months and 2 of them still had pain. One 
was 10 years after and the other was 12 years after the surgery. More than half the donors 
(n=24, 66.7%) complained of abdominal discomfort for the average length of 3.8 months 
and 12 donors still had abdominal discomfort. The longest time after the surgery was a 
man 13 years after the surgery and the average time post surgery for most patients was 8 
years. Many donors (n=23, 63.9%) still had scar numbness for the average length of 10.4 
months. Eleven donors (30.6%) lost their appetite for the average length of 7.2 months, 
but only one donor, a female donor who suffered breast cancer with chemo therapy still 
lost her appetite. Fourteen donors (39.9%) complained of distended stomach after meal 
for the average length of 8.0 months and 9 donors still complained of this. Fourteen 
donors (39.9%) had fatigue for the average length of 12 months and 7 still had fatigue. 
Only 5 donors (13.9 %) had diarrhea and four donors still had diarrhea. Two donors had 
constipation and one of those two donors also had diarrhea. Five donors (13.9 %) had 
back pain and four donors still had back pain. Seven donors (19.4%) had sleeping 
difficulty for the average length of 15 months and one donor still had it. Of these seven 
donors four were the donors who lost their recipient. Four donors reported their other 
symptoms as “Oily meal sits heavy on the stomach”, “When I go for annual health check, 
a doctor always says that the shape of my stomach is strange”, “I cannot sleep on my side 
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and I only can sleep on my back”, and “My right abdominal muscle get cramps in the 
winter.” In particular, the lady who said her abdominal muscle got cramped was the lady 
who participated in the 100km marathon.  
Table 6.  Minor Complications 
 
 Phase 1 (n=41) 
Had the symptom 
Phase 2 (n=36) 
Had the symptom                 Still have the symptom 
Scar pain 
Abdominal discomfort 
Scar numbness 
Loss of appetite 
Distended stomach after 
meal 
Easy to get tired 
Diarrhea 
Constipation 
Back pain 
Difficulty sleeping 
24 
31 
29 
16 
23 
22 
2 
3 
4 
4 
20 
24 
23 
11 
14 
14 
5 
2 
5 
7 
2 
12 
23 
1 
9 
7 
5 
2 
1 
1 
 
On the other hand, the majority of donors (n=31, 86.1%) answered that they felt 
their health condition was the same as others in their general population. Then, five 
donors (13.9%) answered that they felt their health condition was not the same as others 
in their general population. Of these five donors, two donors stated the reason that related 
to the donor surgery, was “fatigue” and “abdominal pain with distention.” Another two 
donors stated the reason that did not relate to the donor surgery, was “overweight” and 
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“chemotherapy for breast cancer.” One donor stated both reasons “fatigue” and “sprain of 
cervical and lumbar vertebrae by automobile accident.” Of these five donors two donors 
lost their recipients after the transplant. 
There were no deaths in the donor population, although nine donors were 
admitted to hospital. Each donor was admitted for a different reason and everybody was 
treated (Table 6). Five donors required clinical visits after the main donor surgery (Table 
6). 
Table 7. Admissions and Clinical Visits after the Donor Surgery 
 
 Reasons for admission Years after  the surgery  N 
1 Autoimmune Hepatitis 12 1
2,3 Plastic surgery of the scar 0,1 2
4 Illus 0 1
5 Lumber Hernia 8 1
6,7 Breast Cancer  4,4 2
8 Testicle Cancer and LFTｓ↑ 5 1
9 Thyroid Gland Cancer 1 1
 Reasons for clinical visit Years after the surgery (n) N 
1 Jaundice and Gastric Ulcer 4 1
2 High serum cholesterol 3 1
3 Panic Syndrome 0 1
4 Abdominal Pain 0 1
5 Diabetes 5 1
 
Four donors developed cancer, but there were no cases of liver cancer. One donor 
was admitted to the hospital to treat liver disease and one donor had a clinical visit for an 
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elevated serum bilirubin. Two donors underwent plastic surgery in order to improve the 
appearance of their abdominal scars. One donor had a psychiatric disorder immediately 
after surgery. He reported that he had a panic disorder after he returned to his work, 
because he had to be absent from work for a month and had a hard time catching up in his 
job. He said that he had this for several months. 
Social Life after the Surgery. Before the surgery, half of the donors (n=18, 50.0%) 
were working full-time, seven (19.4%) part-time, nine (25%) were house wives, one was 
a student, one marked other. After the surgery, about half of the donors (n=19, 52.8%) 
were working full-time, nine (25%) part-time, six (16.7%) were house wives, no student, 
and two marked other. 
Sixteen donors (44.4%) changed their social activity. There were five donors who 
used to work full-time, then one retired because of his age, one resigned because of 
mothering, and three changed to part-time. Of these three donors who gave up working 
full-time, all were donors who lost their recipients. One lost her baby from fulminant 
hepatitis and she had a hard time, then she gave up working full-time. One lost her 
husband several years after the transplant and she developed breast cancer after that, then 
she gave up working full-time. The last one lost her husband soon after the transplant and 
there is no further information about this donor. On the other hand, there were six donors 
who started working full-time. These six donors’ recipients recovered well after the 
transplant and the donor started working because: four donors were relieved from the 
burden of care giving, one donor had to work after divorce, and one donor graduated 
from school. 
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In terms of return to their social activity, the majority (n=26, 72.2 %) said that the 
hospitalization did not effect their life in the long term. Two donors said that they 
changed their working place and four changed their job itself. Of these 6 donors, four 
said that they lost their income for several years and could not do house keeping for 
several years. One donor quit his job completely and one donor reported that he could not 
work overtime and he went to his bed immediately after his work. Two donors said that 
the siblings of their recipient were infants, “I made him/her lonesome during my donor 
operation” and that still affects them. One donor said that he lost income for a several 
months and the other donor said that she could not do housekeeping for a several months. 
Thoughts about Organ Donation.  Concerning their reflections on organ 
transplantation, the majority of donors (n=32, 88.9%) were satisfied that s/he was a live-
donor, but one was not satisfied and three found it hard to say yes or no. Also, the 
majority of donors (n=24, 66.7%) did not wish that there would have been a cadaveric 
donor at the time of transplantation. However, twelve (33.3%) donors said either wished 
strongly or a little, that a cadaveric donor was available at the time so that they would not 
have been called upon to donate their liver. When asked “if you were back to the same 
situation, would you be willing to be a donor again?” the majority of donors (n=25, 
69.4%) answered yes, six donors (13.9%) no and for five donors, it was hard to say yes or 
no. 
The majority of donors (n=25, 69.4%) said that their mental activities are better 
and two said they are worse. Of these two, one donor lost her baby girl after the surgery 
and the other donor worked under stress. All donors reported that they maintain a good or 
the same relationship with their recipients, while two donors said that they had worse 
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relationship with others. Almost all donors had good or the same relationship with other 
family members, relatives and friends, but only two donors said their relationship got 
worse and there were no further information about it. No donors reported having 
difficulties in their sexual life and one donor gave birth to a baby after the surgery. There 
was only one donor who had a baby after the surgery. 
Concerning organ donation, the majority of donors (n=24, 66.7%) thought that the 
number of deceased organ donor transplant operations should be increased. Twenty seven 
donors (75.0%) said that they will be “willing to be a donor” but less than half donors 
(n=15, 41%) had signed a donor card. When they were asked, “If your family member 
should become brain dead and asked you to donate an organ, would you be willing to 
donate an organ?”, twenty donors (55.6 %) said “yes,” two said “no,” and there were 
many donors (n=14, 38.8%) who said “hard to say yes or no.” 
SF-36® 
All subjects. Figure 5 shows the change of SF-36® score of all subjects 
comparable to the Japanese general population from the phase 1 to phase 2. All eight 
subscales, physical functioning, role emotion, role physics, bodily pain, general health, 
vitality, social functioning, mental health, were better than the Japanese general 
population, and there was a significant improvement of mental health. Only the phase 2 
score of general health was slightly lower than the phase 1 study but the changes in 
scores were not significant. Only mental health went up (p<0.05).  
 Focused group. For the phase 1 study, the donors who were within a year after the 
surgery scored lower than those of donors followed up for longer periods and lower than 
the Japanese general population. For the phase 2 study, those who scored lower were 
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focused to measure changes over seven years. Figure 6 shows that those focused patients 
scores improved significantly over the seven year period. 
 
Figure 5. SF-36® scores (Phase 1 vs. Phase 2) 
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Figure 6. SF-36® (Focused Group) 
 
※Significant <0.05 
For this phase 2 study, five donors whose recipient died responded. Of these five 
donors, there were two donors who showed low scores, one who suffered recurrent breast 
cancer and the one who still cannot come to terms with the loss of her child and these 
lowered the average scores of the phase 2 study. 
Anecdotal Note 
There were four donors whose recipients died of which three returned their 
questionnaires adding a note to the researcher.  
The first donor was the mother who lost her baby after the surgery. Her baby girl 
was sent to this transplant hospital on Christmas day because of fulminant hepatitis, but 
she recuperated well without receiving a transplant that time. Several months later, she 
became unconscious again and underwent a transplant. She did not wake up after the 
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transplant and remained in a vegetative state until she died 6 months later. Meantime, her 
father started having a relationship with a teacher of kindergarten where this girl used to 
go. From this mother’s point of view, she became a donor, had to take on many new roles 
and cope with a difficult relationship with her husband. She had a hard time after the 
surgery. She added a comment to the questionnaire saying that she had no regrets of 
being a living donor to save her baby; but that she had been experiencing fatigue 
especially around the anniversary of the donor operation day. She called this an 
“anniversary syndrome.”  She divorced her husband, started new job, and a network for 
sick children. She also published a book based on her transplant story. 
The second donor was a wife of a patient who underwent a transplant because of 
Hepatitis B. When she answered the phase 1 questionnaire, her husband was still alive. 
She added a comment saying that, “My husband said that he does not need me anymore, 
because I already gave a portion of my liver. Even if this was a joke, I was hurt.” 
However, she answered that she was satisfied with living organ donation. During the next 
seven years, she lost her husband from lung cancer and she also developed breast cancer. 
She added a comment regarding her physical condition and said it was nice to hear from 
the transplant team. She answered that she was dissatisfied with living organ donation 
and she would not be a donor again if she were in the same situation. 
The third donor was a daughter of a patient (her mother) who underwent a 
transplant because of fulminant hepatitis. She was in her 20s at that time. Because the 
onset of fulminant hepatitis was acute and sudden without any medical history, this lady 
had to make a decision in a short period of time. Unfortunately, her mother died within 
several days after the transplant. The person who became the angriest was the husband of 
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the patient who died who was also the father of this donor. He showed his anger to the 
transplant team and told the transplant doctors to “carry his wife’s coffin to his car.”  For 
this phase 2 study, she wrote about her current life, “Me and my father are doing fine. My 
first child is now a high school student and the second one is a junior high school student. 
I remember that they were very small when I faced the donor operation. Without support 
from my family, I think I would not have been able to donate at that time. After many 
years, there were updates on the news about living organ transplants. When I heard about 
donors’ death, I often thought that it could have happened to me. Then, I think I was very 
selfish at that time, because I was only thinking about myself. One to two years after the 
surgery I still had pain and discomfort in my back, but I am doing very well now. I think 
I have to live my own life well because my mother taught me so. Thank you very much 
for your support.”
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4.4 Discussion 
Quality of life 
This is the first, long-term, quantitative study of living liver donors in Japan. The 
year of 2000 to 2001 was the time that the main target of living donor liver 
transplantation shifted from the pediatric to the adult patients. In the phase 1 study which 
was completed in 2002, the donors within a year after surgery showed low scores on the 
SF-36® and this may reflect that many donors had a difficult time after the operation 
because of lack of full understanding and preparations. The shift to adult-to-adult 
transplantation required a different preparation from the adult-to-pediatric program. 
Overall, all donors showed improvement seven years after surgery and most feel they 
were the same when compared to others in the population who were not donors. 
Compared to previous QOL research regarding living liver donors, major 
complications occurred in 17.0% (n=7) of the donors which was nearly the same with 
Trotter’s research (2001) that reported 16%. While Trotter (2001) reported that 75% of 
donors answered that they recovered fully at a mean time of 3.4 months for this phase 1 
study, 69.0 % of donors answered that they fully recovered at a mean time of 2.4 years, 
and for the phase 2 study, 61.0 % of donors answered that they fully recovered at a mean 
time of 10.1 years. The main symptoms that these donors had were fatigue, scar 
numbness, and abdominal discomfort, but those symptoms lessened over the years. 
However, gastrointestinal symptoms such as diarrhea and constipation did not improve. It 
is hard to distinguish whether or not the gastrointestinal symptoms were related to the 
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surgery or to other factors (prior history, age, etc), but these donors reported experiencing 
these problems. 
Beaver and colleagues (2001) reported that there were no significant low QOL 
scores in their donors but that there were 22% of the donors who were readmitted to the 
hospital to treat complications. There was less readmission to treat complications for this 
study. Only two donors had plastic surgery related to the scar and one donor developed 
autoimmune hepatitis. Beaver and colleagues (2001) also reported that the mean recovery 
time was 15 weeks and this phase 1 study showed 17.3 weeks, and phase 2 as 11.5 weeks. 
The mean recovery time was about the same as in previous research. 
From a transplant team’s view, they work hard for donors to recover from the 
surgery first and discharge early without surgical complication. Moreover, in order to 
shorten the length of hospital stay and standardize care for donors, there are many 
transplant teams use clinical pathway for donor admission. However, from the finding of 
this study, there were many donors who still suffer symptoms such as scar pain, 
abdominal discomfort, scar numbness, loss of appetite, distended stomach after each meal, 
fatigue, diarrhea, constipation, back pain, and difficulty sleeping over seven years after 
the surgery. Therefore, long-term observation for these donors is necessary. 
There were no data of previous health condition of those donors, because only 
healthy person could be a donor. Therefore, being healthy was a precondition of donor. 
However, minor pre-operative conditions such as easy to have diarrhea or tend to have 
“keloid” scar (cramped scar) are not take seriously and those condition will affect to how 
they perceive their QOL. Gathering all physical information about a donor will be a key   
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to help each donor to recuperate well after the donation. Therefore, thorough physical 
examination by coordinators or/and nurses is important. 
There are only 31 transplant coordinators employed on transplant teams in Japan 
(Japanese Transplant Coordinators Organization), and majority of transplant teams do not 
employ a transplant coordinator. Because transplant surgery itself do not make a big 
benefit to Japanese hospital and many hospitals can’t afford to employ one. However, 
this research findings showed that many donors have been suffering from symptoms over 
long time and those might be impacted to their perception of QOL. Therefore, each 
transplant team should have a transplant coordinator in order to follow up for a long time. 
Moreover, donors may have difficulty to talk to their doctors and it is much easier and 
safer for them to provide an easy access to their transplant coordinator. 
Decision to donate 
Concerning their decision to donate, all donors signed informed consent forms 
twice, before starting the donor evaluation and before the donor operation. Despite the 
many safe guards in place to ensure informed consent, many donors did not feel that they 
had a free choice in donating once they were identified as an acceptable donor. During 
their preparation in the phase 1 study, ten donors reported that they felt pressure from the 
medical staff and thirteen felt pressure to donate from their recipients or family members. 
However, in both studies, most donors (88%) were satisfied with their own decision 
making process.  
Because all donors signed informed consent forms twice, theoretically they made 
their decision based on their autonomy which was one of the six bioethical standards 
related to Husted’s theory. The only question which assessed their decision making was 
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“Are you now satisfied that you were a live-donor.”  According to Husted’s theory, a 
patient makes decisions based upon a patient’s trust with the health care professional and 
patient agreement (Husted and Husted, 2008). Therefore, living donors need to be 
continually supported by the transplant team and the decisions reassessed throughout the 
process. 
The findings showed improvement of QOL over seven years, but the majority 
(78%) were still suffering from symptoms. It would be important to inform this finding 
for future donor candidates with precise but sincere manners. Because giving up living 
donation will mean that there is no chance of getting organ transplant for the recipient. As 
a transplant coordinator, to support each donor’s decision making process by providing 
benefits and risks of live organ donation will be a key issue for the further development 
of living donor program as well as organ transplantation itself in Japan. 
Organ transplantation in Japan 
Despite their caveats in relation to living organ donation, the information obtained 
is of interest and was an attribute to the courage and generosity of the donor patients. 
Since cadaveric organ donation has played almost no part in liver transplantation in 
Japan, patients dying of liver disease and suitable for transplantation present to their 
families, friends and medical and nursing clinicians as tragic cases for whom a major 
sacrifice of living organ donation is the only possibility that can rescue them. 
The generous response in so many cases has been a testimony of humanity but in 
each case a major stress was thrust upon the patient’s family that previously was 
unprecedented in medical practice. Those who came forward as potential donors may do 
so out of altruistic love, but a donor having been selected, the rest of the family members 
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inevitably have a sense of guilt feeling “perhaps it should have been me”. The medical 
and nursing staff has a key and difficult task of acting as advocates for the interests and 
wellbeing of the donors since they are aware of the mortal plight of the recipient. 
 The outcome in the short- and the long-term can be a dynamic source of stress for 
the donor and the rest of the family. Donor post-operative morbidity, sometimes serious 
and prolonged, was not uncommon and donor death is a tragedy of immense proportions 
that will stay as a lasting traumatic mental assault for the family and health care workers 
to bear. 
Results from this study demonstrate an overall positive and optimistic outlook, 
but one cannot avoid the conclusion that there is a serious need for cadaveric organ 
donation to be established in Japan for those in need of kidney, liver and lung grafts and 
is an essential requirement for those dying of heart disease. 
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CHAPTER 5 
SUMMARY AND RECOMMENDATIONS 
 
5.1 Introduction 
The work of this dissertation is summarized and the results indicate 
recommendations for future QOL studies of living liver donors.  
5.2 Summary 
In 2009, the Japanese Congress passed a new transplant law in 2010 which 
permits organ procurement from children and allows organ donation without written 
consent by a donor. Moreover, the most distinguished society in the field of 
transplantation called the Transplant Society will present their “Istanbul Declaration” 
("Organ trafficking and transplant tourism and commercialism: the Declaration of 
Istanbul," 2008) which stresses the need for organ self sufficiency for each country to the 
World Health Organization (WHO) and the WHO will recommend this declaration 
worldwide. This means Japan will have to stop sending patients abroad in order to 
receive organ transplants and we have to promote organ donation in Japan and develop 
our hospitals to increase organ donation. 
From this study, most of the live liver donors recuperated well over the long-term, 
but many continue to have minor complications and some lost their income or changed 
their job after their surgery. Most donors were satisfied to have been a donor for their 
loved one, but some donors still have complicated feelings about the procedure. No donor 
developed liver cancer over the years of study, but some suffered from cancer elsewhere 
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which is similar in distribution to the general population. Because seven years had passed 
after the phase 1 study, some donors were in their seventies, but most answered that they 
feel as well as most people of their age group. It is difficult to measure the QOL, but this 
kind of answer suggests that living donation can be a good choice. 
A surprising result is that many donors still have complications (although minor 
ones) seven years after their operation. Moreover, they discontinued seeing their doctors 
over the long term. The reasons for discontinuing follow up care must be examined. 
Future donors must be apprised of the possibility minor complications over the long term 
and must be encouraged to continue follow up care. Donors should be encouraged also to 
inform the transplant team of their minor complications following surgery.  
To rescue patients with organ failure, new techniques such as artificial organs and 
regenerative medicine are being developed by many scientists worldwide. For instance, 
Yamanaka reported transforming skin cells to primitive cells similar to embryonic stem 
cells, called “induced pluripotent” stem cells (Yamanaka, 2007).  This removes the 
ethical worries of working with embryonic stem cells. Also, in 2008 a collaborative 
group of English and Spanish workers reported a trachea transplantation which required 
both transplant and regenerative medical knowledge and techniques (Macchiarini et al., 
2008). It is very difficult to make an artificial liver, because the liver has so many 
functions and a complicated anatomy. However, a portable artificial kidney in the 
development stage weights only 2 pounds (AWAK, 2009). 
Japan is a country which is behind other developed countries in the field of organ 
transplantation. However, there is a hope that we will develop efficient transplant 
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programs combined with new technologies, and, if so, there will be a need for nurses to 
explain this developing medical practice to our patients. 
5.3 Recommendations 
The aim of this study was to investigate the QOL of live liver donors over the 
long-term. The study showed improvement of their QOL using one of the standardized 
questionnaires, SF-36®. Standardized surveys tend to lack both the specificity and the 
sensitivity necessary for capturing all of the particular QOL issues that some donors may 
have. Also, the technique of comparing the scores of donors versus the general 
population on such standardized questionnaires may be misleading as donors have 
already been selected for good health and psychological stability, an essential 
requirement for donation. 
Future Research 
For future research, the qualitative method of in-depth individual interviews will 
allow for the exploration of the complex and often sensitive issues involved in quality of 
life assessment. Issues such as relationship with their recipients, marital tension, financial 
difficulties, problems with other family members, and the donor’s own sense of physical, 
social and emotional well-being, can be expressed in full as rapport is built during the 
course of an in-depth interview. All of the donors were determined to be in excellent 
health prior to donating.  
To measure the impact of living donation for donors, a prospective study should 
be conducted with the purpose of following the participants closely over time. 
Participants could be studied from the time they enter the transplant system and for years 
after the donation in a well designed study.  
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Limitations 
This researcher has attempted to analyze the post-operative fate of living liver 
donors at one year and then beyond seven years. Of the donors operated on at the Keio 
University Hospital, all those eligible for this study were sent a voluntary questionnaire 
covering physical, social, and emotional recovery at one and seven years. 
Problems related to retrospective analyses are well recognized, namely: 
1. It is unusual to obtain 100% response rate to a questionnaire investigation. In this 
study, 46 donors were approached in the phase 1 study, 41 (89.1%) responded. 
In the phase 2 study, from 49 questionnaires sent 36 (73.4%) replied. 
2. Risk of bias of poor outcome in non responders. 
Having made the sacrifice of submitting to a major surgical procedure there may 
be reluctance on the part of the donor to admit their weakened health status. It will be 
important to query the donor regarding their feelings regarding their choice to be a donor 
with respect to the outcome of the recipient.  
Also, this study was based on a single-center with a small sample size, thus 
limiting the general application of the results. Therefore, caution is necessary in applying 
the results to the general population of live donors. 
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APPENDIX A 
Questionnaire for living-liver donors (Phase 1) 
 
I. First, tell us about yourself. 
 1. Gender:   (  ) male 
     (  ) female 
 2. Age at the transplant (  ) 20s 
     (  ) 30s 
     (  ) 40s 
     (  ) 50s 
     (  ) 60s 
 3. Year of the operation:       . 
 4. The recipient of your liver 
     (  ) child 
     (  ) parent 
     (  ) sibling 
     (  ) spouse 
 
II. Tell us about your health condition  
1. Compare your past health condition, how do you feel now? 
 (  )  I feel my health condition is better than before the operation  
  → answer 1) 2) then go to 2. 
 (  )  I recuperated perfectly well. I feel the same as I did before the operation.  
→ answer 2), then go to 2. 
 (  )  I have not recuperated well completely. → answer 3), then go to 2. 
1) How do you feel better than before?                                                              . 
2) How long did it take to fully recuperate?  
     About  mo.   week after the operation. 
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3) If you have not recuperated well, how much do you feel you recuperated so far. 
 (  ) < 25% 
 (  ) 25~50% 
 (  ) 50~75% 
 (  ) ↑75% 
Why do you feel you have not recuperated well?  What makes you feel in that way?         
                                   . 
 
2. Today, do you have any limitation when doing physical activities, such as playing 
golf, swimming, business trip, working for long time, traveling?  
 (  ) I have limitations   →answer 1), then go 3. 
 (  ) I do not have any limitation  →answer 2), then go 3. 
1) Please tell us about your limitation. 
_________________________________________________________________-_____                                 
2) Today, you do not have any limitation, but how long did you have limitations after 
the operation.    About  mo.   week after the operation. 
3. Before the operation, how long did you assume the length of full recuperation would 
take? 
      About  mo.   week after the operation. 
4. Did you recuperate as the same pace as you assumed? 
 (  )  I recuperated faster than I assumed. 
 (  )  I recuperated as the same pace that I assumed. 
 (  )  I recuperated slower than I assumed. 
 
5. Did you have any symptoms after the discharge?  If yes, please note for how long you 
have had that symptom. Circle “Still have it” if you still have that symptom. 
 (  )  Scar pain   About mo. week after the operation / Still have it. 
 (  )  Abdominal discomfort 
    About mo. week after the operation / Still have it. 
 (  ) Scar numbness About mo. week after the operation / Still have it. 
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 (  )  Loss of appetite About mo. week after the operation / Still have it. 
(  )  Distended stomach after meal 
    About mo. week after the operation / Still have it. 
 (  )  Easy to get tired (weakness) 
    About mo. week after the operation / Still have it. 
 (  )  Diarrhea  About mo. week after the operation / Still have it. 
 (  )  Constipation About mo. week after the operation / Still have it. 
 (  )  Back pain  About mo. week after the operation / Still have it. 
 (  )  Difficulty sleeping 
    About mo. week after the operation / Still have it. 
 (  )  Other  About mo. week after the operation / Still have it. 
6. Have you been diagnosed with any kind of disease after the discharge? 
                                     . 
 
III. Tell us about your social life. 
1. Please note any changes regarding your social activity, such as work, housekeeping, 
schooling. 
1) What was your previous social life before the operation? 
 (  )  Working full-time 
 (  )  Working part-time 
 (  )  House wife 
 (  )  Student 
 (  )  Other           
 
2) What is you social life after the operation 
 (  )  Working full-time 
 (  )  Working part-time 
 (  )  House wife 
 (  )  Student 
 (  )  Other           
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3) Was there any change in your social activities before and after the operation? 
 (  )  No 
 (  )  Yes  How did it change?   
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
2. When was the first time that you went back to your social activity, work, school, 
housekeeping?      About  mo  week / I have not gone back, yet. 
 
3. Today, did you go back to your social activity completely? 
  (  )  Yes →answer 1) then go 4. 
  (  )  No  →answer 2) then go 4. 
1) How long did it take to go back to you social activity completely? 
       About   mo   week after the operation.  
2) If you have not gone back completely to your social activity, do far do you feel you 
gotten back to your social activity? 
  (  ) ↓25% 
  (  ) 25~50% 
  (  ) 50~75% 
  (  ) ↑75% 
 Why or what make you think in that way? 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
                                                                       
4. Before the operation, did you think about how much time it might take for you to go 
back to your social activities?   About   mo   week after the operation. 
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5. Did you go back to work as the same pace as you expected? 
  (  ) It was faster than I expected 
  (  ) It was the same as I expected 
  (  ) It was slower than I expected 
 
IV. Tell us about your financial and social support. 
1. Did your income decline because of being a live donor? 
 (  ) yes 
 (  ) no 
2. Did you take a leave from work as official paid absence? 
 (  ) yes 
 (  ) yes, but partially 
 (  ) not at all 
3. Did you use any financial support to pay for your hospital fee, surgical fee and any 
other expense relate to your operation? 
(  ) Your private life insurance  
(  ) Support from company where you work 
(  ) Public aid 
(  ) Support from other family members or relatives 
(  ) Other                                        
 
V. Tell about your thought in regard to organ transplantation based on your experience. 
1. Had you ever heard about living-donor liver transplantation before becoming 
involved? 
 (  ) yes, I knew it very well 
 (  ) yes, I have heard about it, but I did not know well. 
 (  ) no, I have never heard about it. 
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2. How did you know about living-donor liver transplantation? 
 (  ) books, newspapers 
 (  ) TV 
 (  ) friend, family members, 
 (  ) doctors, nurses 
 (  ) other 
 
3. How did you decide to be a live-donor for your recipient? 
 (  ) based on my knowledge from books, newspapers, TV 
 (  ) based on meeting with my friends, family members 
 (  ) based on meeting with my doctors 
 (  ) other 
                  
4. How much did you understand the explanations about live-liver donation before the 
operation? 
 (  ) I was able to understand completely. 
 (  ) I was able to understand mostly. 
 (  ) I was able to understand about the half. 
 (  ) I was not able to understand well 
 (  ) I could not understand at all 
 
5. After the operation, how was the pain? 
 (  ) slightly painful 
 (  ) moderately painful 
 (  ) severely painful 
 (  ) very, very painful 
 
6. Was the pain more painful than you expected? 
 (  ) It was worse than I expected. 
 (  ) It was the same as I expected 
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 (  ) It was the better than I expected 
 
7. Was the length of hospitalization longer than you expected? 
 (  ) It was longer than I expected 
 (  ) It was the same as I expected 
 (  ) It was shorted than I expected 
 
8. Tell us about any changes in following matters. 
1) mental activities 
   (  ) better   (  ) the same   (  ) worse 
2) relationship with recipient 
   (  ) better   (  ) the same   (  ) worse 
3) relationship with other family members, relatives and friends 
   (  ) better   (  ) the same   (  ) worse 
4) sexual activities  
   (  ) better   (  ) the same   (  ) worse 
 
9. (For women only,) Did you get pregnant or have a baby? 
 (  ) yes 
 (  ) no 
 
10. Tell us about your donation 
1) Did you feel any pressure to be a donor by medical staff? 
 (  ) Felt pressure strongly 
 (  ) Felt pressure a little 
 (  ) Not at all 
 
2) Did you feel any pressure to be a donor by your recipient or family members? 
 (  ) Felt pressure strongly 
 (  ) Felt pressure a little 
 (  ) Not at all 
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3) Did you wish that there would have been a cadaveric donor at the time of 
transplantation? 
 (  ) Wished strongly 
 (  ) Wished a little 
 (  ) Not at all 
 
4) Are you now satisfied that you were a live-donor? 
 (  ) yes 
 (  ) no 
 (  ) hard to say yes or no 
 reason for the answer                                            
________________________________________________________________________
_______________________________________________________________________ . 
                                                                  
5) Would you recommend to others to be a live-donor? 
 (  ) yes 
 (  ) no 
 (  ) hard to say yea or no 
reason for the answer                                                  
________________________________________________________________________
________________________________________________________________________. 
                                                                  
11. Tell us about your thought of the transplant system. 
1) Was there any missing service before the operation? 
 (  ) Information about operative procedure and test findings 
 (  ) Information about cost and paper works 
 (  ) Mental support 
 (  ) Other                                               
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2) Was there any missing service after the operation? 
 (  ) Long-term care or medical follow-up 
 (  ) Information about cost and paper work 
 (  ) Emergent access when I feel sick 
 (  ) Mental support 
 (  ) Other                                                
 
12. Tell us about your thought of transplantation 
1) Do you think the number of cadaveric donor should be increased? 
 (  ) yes 
 (  ) no 
 (  ) hard to say yes or no 
 
2) If you become brain dead, will you be willing to be a donor again? 
 (  ) yes 
 (  ) no 
 (  ) hard to say yes or no 
 Do you have a donor card?  (  ) yes   (  ) no 
 
3) In Japan, there is a limitation to be a donor. (To be a donor, you have to be within the 
third degree biologically, or spouse.)  What are your thoughts about this limitation? 
 (  ) within the second degree and spouse is enough  
  (parent/child, grandparent, siblings) 
 (  ) within the third degree and spouse is enough 
  (+cousin, aunt/uncle) 
 (  ) beyond the limitation, but within the family group 
 (  ) beyond the limitation, and outside of the family is okay 
 (  ) other                                                
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13. Our national insurance will cover for liver transplant for children who are under age 
15, but not for adults. Those adult patients who need a liver transplant have to pay by 
themselves, even s/he needs a new liver to live. 
1) Have you ever heard about it? 
 (  ) I knew about it very well. 
 (  ) I have heard about it, but I don’t know about it well. 
 (  ) I have never heard about it. 
2) What do you think of this situation? 
 (  ) The national insurance should cover the transplant fee for all patients who need a 
new liver. 
 (  ) The national insurance should cover the transplant fee for more patients who need 
a new liver. 
 (  ) The national insurance should not change the rule 
 (  ) The national insurance should not cover any transplant at all. 
 
14.  Any general comment about the transplant.                                                                                                 
________________________________________________________________________
_______________________________________________________________________  . 
 
15. Are you willing to share your experience with others who are thinking of future 
donation? 
 (  ) yes 
 (  ) no 
 (  ) hard to say yes or no 
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APPENDIX B 
SF-36®v2 Health Questionnaire 
 
This survey asks for your views about your health. This information will help you keep 
track of how you feel and how well you are able to do your usual activities. 
 
Please answer every question. Since questions may look like others, but each one is 
different. Please take the time to read and answer each question carefully, and mark on 
the number that best describes your answer. Thank you for completing this survey. 
 
1) In General, would you say your health is: 
1. Excellent 
2. Very good 
3. Good 
4. Fair 
5. Poor 
 
2) Compared to one year ago, how would you rate your health in general now? 
1. Much better now than one year ago 
2. Somewhat better now than one year ago 
3. About the same as one year ago 
4. Somewhat worse now than one year ago 
5. Mush worse now than one year ago 
 
3) The following questions are about activities you might do during a typical day. Does 
your health now limit you in these activities? If so, how much? 
a. Vigorous Activities, such as running, lifting heavy objects, participating in 
strenuous sports 
1. Yes, limited a lot 
2. Yes, limited a little 
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3. No, not limited at all 
b. Moderate Activities, such as moving a table, pushing a vacuum cleaner, 
bowling or playing golf 
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
c. Lifting or carrying groceries 
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
d. Climbing several flights of stairs 
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
e. Climbing one flight of stairs 
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
f. Bending, kneeling, or stooping 
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
g. Walking more than a mile 
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
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h. Walking several hundred yards 
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
i. Walking one hundred yards 
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
j. Bathing or dressing yourself 
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
4) During the past 4 weeks, how much the time have you had any of the following 
problems with your work or other regular daily activities as a result of your physical 
health? 
a. Cut down on the amount of time you spent on work or other activities 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
b. Accomplished less than you would like 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
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5. None of the time 
c. Were limited in the kind of work or other activities 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
d. Had difficulty performing the work or other activities (for example, it took 
extra effort) 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
5) During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 
problems (such as feeling depressed or anxious)? 
a. Cut down on the amount of time you spent on work or other activities 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
b. Accomplished less than you would like 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
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5. None of the time 
c. Did work or activities less carefully than usual 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
6) During the past 4 weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, neighbors, 
or groups? 
1. Not at all 
2. Slightly 
3. Moderately 
4. Quite a bit 
5. Extremely 
 
7) How much bodily pain have you had during the past 4 weeks? 
1. None 
2. Very Mild 
3. Mild 
4. Moderate 
5. Severe 
6. Very Severe 
 
8) During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
1. None 
2. A little bit 
3. Moderately 
4. Quite a bit 
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5. Extremely 
9) These questions are about how you feel and how things have been with you during 
the past 4 weeks. For each question, please give the one answer that comes closest to 
the way you have been feeling. How much of the time during the past 4 weeks… 
a. Did you feel full of life? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
b. Have you been very nervous? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
c. Have you felt so down in the dumps that nothing could cheer you up? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
d. Have you felt calm and peaceful? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
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e. Did you have a lot of energy? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
f. Have you felt downhearted and depressed? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
g. Did you feel worn out? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
h. Have you been happy? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
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i. Did you feel tired? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
10) During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting friends, relatives, etc.)? 
1. All of the time 
2. Most of the time 
3. Some of the time 
4. A little of the time 
5. None of the time 
 
11) How FRUE or FALSE is each of the following statements for you? 
a. I seen to get sick a little easier than other people 
1. Definitely true 
2. Mostly true 
3. Don’t know 
4. Mostly false 
5. Definitely false 
 
b. I am as healthy as anybody I know 
1. Definitely true 
2. Mostly true 
3. Don’t know 
4. Mostly false 
5. Definitely false 
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c. I expect my health to get worse 
1. Definitely true 
2. Mostly true 
3. Don’t know 
4. Mostly false 
5. Definitely false 
 
d. My health is excellent 
1. Definitely true 
2. Mostly true 
3. Don’t know 
4. Mostly false 
5. Definitely false 
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APPENDIX C 
Questionnaire for living-liver donors (Phase 2) 
 
 
I. Tell us about yourself. 
1. Gender   (   ) male 
     (   ) female 
2. Age at the transplant  (   ) 20s     → Age (now)  (   ) 20s 
     (   ) 30s   (   ) 30s 
     (   ) 40s   (   ) 40s 
     (   ) 50s   (   ) 50s 
     (   ) 60s   (   ) 60s 
         (   ) 70s 
 3. Year of the operation:               . 
 4. The recipient of your liver: (   ) child 
     (   ) parent 
     (   ) sibling 
     (   ) spouse 
 
II. About your health condition 
1. Compare your past health condition, how do you feel now? 
(  )  I feel my health condition is better than before the operation  
 → answer 1) 2) then go to 2. 
(  )  I perfectly recuperated well as the same as health condition before the 
operation. 
  → answer 2), then go to 2. 
 (  )  I have not recuperated well completely. → answer 3), then go to 2. 
1) How do you feel better than before? 
                                                                           . 
2) How long did it take to fully recuperate? 
      About  year after the operation. 
3) If you have not recuperated well, how much do you feel recuperate so far. 
 (  ) ↓25% 
 (  ) 25~50% 
 (  ) 50~75% 
 (  ) ↑75% 
Why do you feel you have not recuperated well? What makes you feel in that way?         
              . 
2. Today, do you have any limitation for doing physical activities, such as playing 
golf, swimming, business trip, working for long time, traveling?  
 (  ) I have limitations   →answer 1), then go 3. 
 (  ) I do not have any limitation  →answer 2), then go 3. 
1) Please tell us about your limitation. 
                                                                         . 
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2) Today, you do not have any limitation, but how long did you have limitation 
after the operation. 
      About  year after the operation. 
 
3. Before the operation, how did you assume of the length of full recuperation 
would take? 
      About  year after the operation. 
 
 
 
 
4. Did you recuperate as the same pace as you assumed? 
 (  )  I recuperated faster than I assumed. 
 (  )  I recuperated as the same pace that I assumed. 
 (  )  I recuperated slower than I assumed. 
 
5. Did you have any symptoms after the discharge?  If yes, please note for how long 
you have had that symptom. Circle “Still have it” if you still have that symptom. 
 (  )  Scar pain      About year after the operation / Still have it. 
 (  )  Abdominal discomfort About year after the operation / Still have it. 
 (  )  Scar numbness    About year after the operation / Still have it. 
 (  )  Loss of appetite    About year after the operation / Still have it. 
 (  )  Distended stomach after meal 
       About year after the operation / Still have it. 
 (  )  Easy to get tired (weakness) 
       About year after the operation / Still have it. 
 (  )  Diarrhea     About year after the operation / Still have it. 
 (  )  Constipation    About year after the operation / Still have it. 
 (  )  Back pain     About year after the operation / Still have it. 
 (  )  Difficulty sleeping About year after the operation / Still have it. 
 (  )  Other        About year after the operation / Still have it. 
 
6. Do you feel your health condition is the same as people who are in your age 
group? 
(   ) Yes, I am the same as people who is in my age group. 
(   ) No → Why? 
1) Reasons relate to donor operation (e.g. Scar pain) 
                                                                . 
2) Reasons which not relate to donor operation (e.g. Automobile accident) 
                                                                 . 
 
7. Have you been diagnosed with any kind of illness after the discharge? 
< Hospitalization> 
Year(onset) Dx:                             (  ) still have it (  ) treated 
Year(onset) Dx:                             (  ) still have it (  ) treated 
Year(onset) Dx:                             (  ) still have it (  ) treated 
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(Comment:                                                      ) 
 
< Clinic visit> 
 Year(onset) Dx:                            (  ) still have it (  ) treated 
 Year(onset) Dx:                            (  ) still have it (  ) treated 
 Year(onset) Dx:                            (  ) still have it (  ) treated 
 (Comment:                                                      ) 
 
III. About your social life 
1. Please note any changes regarding your social activity, such as work, housekeeping, 
schooling. 
1) What was your previous social life before the operation? 
 (  )  Working full-time 
 (  )  Working part-time 
 (  )  House wife 
 (  )  Student 
 (  )  Other           
 
2)  What is you social life after the operation 
 (  )  Working full-time 
 (  )  Working part-time 
 (  )  House wife 
 (  )  Student 
 (  )  Other           
 
2. You must been out of work, school, or housekeeping for a certain period of time 
when you were hospitalized for donation. Did that effect for your life for long term? 
(   ) No 
(   ) Yes  → How did it effect? (Please check as many as you want.) 
  (  ) I did not change my job, but I changed working place. 
  (  )  I changed my job itself. 
  (  )  I lost my income for several years. 
  (  )  I lost my income continuously. 
  (  )  I was absent from my school for long time. 
  (  )  My grades at school had slipped. 
  (  )  I could not do housekeeping for several years. 
  (  )  I could not do housekeeping continuously. 
  (  )  Others                              
 
IV. About your thought in regard to organ transplantation based on your experience. 
 
1.   Are you now satisfied that you were a live-donor? 
(  ) yes 
(  ) no 
(  ) hard to say yes or no 
Reason for the answer                                               . 
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2.  Tell us about any changes in following matters. 
a. mental activities 
   (  ) better   (  ) worse   (  ) the same 
b. relationship with recipient 
   (  ) better   (  ) worse   (  ) the same 
c. relationship with other family members, relatives and friends 
   (  ) better   (  ) worse   (  ) the same 
d. sexual activities 
(  ) better   (  ) worse   (  ) the same 
e. (For women only,) Did you get pregnant or have a baby? 
  (  ) no 
  (  ) yes  Pregnancy  (  ) 
     Delivered  (  ) 
 
3. About your thoughts in regard to live organ donor transplantation. 
1) Did you wish that there would have been a cadaveric donor at the time of 
transplantation? 
(  ) wished strongly 
(  ) wished a little 
(  ) not at all 
2) If you were back to the same situation, will you be willing to be a donor 
again? 
(  ) yes 
(  ) no 
(  ) hard to say yes or no 
             Reason for the answer                                    . 
 
4. About your thoughts in regard to deceased organ donor transplantation. 
1) Do you think that the number of deceased organ donor transplantation should 
be increased? 
(  ) yes 
(  ) no 
(  ) hard to say yes or no 
 
2) If you become brain dead, will you be willing to be a donor again? 
(  ) yes 
(  ) no 
(  ) hard to say yes or no 
  Do you have a donor card?  (  ) yes  (  ) no 
 
3) If your family member become brain dead and showed their wish for organ 
donation, will you be agree for organ donation? 
(  ) yes 
(  ) no 
(  ) hard to say yes or no
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APPENDIX D 
Duquesne University Institutional Review Board 
Protocol #09-84 
Approval Date: 09/30/2009 
Expiration Date: 09/30/2010 
 
 
DUQUESNE UNIVERSITY 
 
600 FORBES AVENUE 
PITTSBURGH, PA 15282 
 
 
Dear Sir/Madam 
 
I am a PhD student at Duquesne University School of Nursing. As part of the 
requirements for graduation I am conducting a study looking at the quality of life of 
live donor patients. It has been seven years since we started a living liver transplant 
program at Keio University Hospital. To improve our clinical practice and patient care, 
I would like to ask you to participate in my research by completing the enclosed 
questionnaires. By returning the completed questionnaires, you are providing consent. 
 
- It is your choice to decide whether to participate or not 
 
- By responding to these questionnaires, we will assume that you agreed to participate 
 
- If there is a difficult question to answer, you do not need to answer it. 
 
- The data will be used for academic purposes and you will never be identified by 
your name. 
 
- And your decision whether to be in the study will not affect your treatment in any 
way. 
 
Keio University Hospital, Transplant Coordinator  
Duquesne University School of Nursing, PhD 
Etsuko Soeda, RN, MSN, CTC 
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APPENDIX E 
 
Duquesne University Institutional Review Board 
Protocol #09-84 
Approval Date: 09/30/2009 
Expiration Date: 09/30/2010 
 
 
DUQUESNE UNIVERSITY 
 
600 FORBES AVENUE 
PITTSBURGH, PA 15282 
 
 
CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
 
 
 
 
TITLE: Organ Donation in Japan – A 
Longitudinal Study of Quality of Life of 
Living Donors 
 
 
INVESTIGATOR: Etsuko Soeda, MSN, RN 
 
35 Shinanomachi, Shinjuku-ku 
Tokyo, Japan, 160 8285 
 +81-3-5363-2198 
 
 
ADVISOR: L. Kathleen Sekula, PhD, APRN 
Duquesne University, School 
of Nursing 
524Fisher Hall 
Pittsburgh, PA 15282-
1760 
+1-412-396-4865 
 
 
SOURCE OF SUPPORT: This study is being performed as partial 
fulfillment of the requirements for the 
doctoral degree in nursing at Duquesne 
University. This study is supported by a 
grant from Keio Gijuku Academic 
Development Funds. 
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Duquesne University Institutional Review Board 
Protocol #09-84 
Approval Date: 09/30/2009 
Expiration Date: 09/30/2010 
 
PURPOSE: The purpose of this study is to measure 
how Japanese living donor liver 
transplant donors doing well after seven 
years from the first study. You are being 
asked to fill out a questionnaire on 
quality of life. This will take 
approximately 15 minutes. These are the 
only requests that will be made of you. 
 
RISKS AND BENEFITS: There are no risks greater than those 
encountered in everyday life. 
 
COMPENSATION: There is no compensation by participate 
this study and participation in the 
project will require no monetary cost 
to you. A stamped envelope is 
provided for return of your response to 
the investigator. 
 
CONFIDENTIALITY: Your name will never appear on any 
survey or research instruments. No 
identity will be made in the data 
analysis. All written materials and 
consent forms will be stored in a locked 
file in the researcher's office. Your 
response(s) will only appear in statistic 
data summaries. All materials will be 
destroyed at the completion of the 
research. 
 
RIGHT TO WITHDRAW: You are under no obligation to participate 
in this study. You are free to withdraw 
your consent to participate at any time.
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Duquesne University Institutional Review Board 
Protocol #09-84 
Approval Date: 09/30/2009 
Expiration Date: 09/30/2010 
 
SUMMARY OF RESULTS: A summary of the results of this 
research will be supplied to you, at no 
cost, upon request. 
 
 
VOLUNTARY CONSENT: I have read the above statements and 
understand what is being requested of 
me. I also understand that my 
participation is voluntary and that I am 
free to withdraw my consent at any time, 
for any reason.  
  On  these  terms,  I  certify  that  I  am 
willing to participate in this research 
project. By continuing with 
the survey, I consentto participate in 
this research study. 
 
 
I  understand  that  should  I  have  any  
further 
questions about my participation in this 
study, I may call Etsuko Soeda, the 
Principal Investigator (03-5363-2198), Dr. 
Kathleen Sekula, the Advisor (+1-412-
396-4865), and Dr. Paul Richer, Chair of 
the Duquesne University Institutional 
Review Board (412-396-6326). 
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